Gastroenterology

Neonatal Jaundice

Neonatal jaundice is yellowish discoloration of the skin and sclera in newborns, typically occurring within the first 28 days of life, due to elevated unconjugated bilirubin from immature hepatic conjugation and increased red blood cell turnover.

Exam domainOne-glance essentials
Definition / diagnosis
  • Yellow discoloration from elevated bilirubin in the first 28 days [1]
  • Distinguish unconjugated from conjugated hyperbilirubinaemia [1]
Epidemiology / risks
  • Prematurity, haemolysis, bruising and poor feeding raise severe-jaundice risk [1]
  • G6PD deficiency and blood-group incompatibility are important locally [1]
Core mechanism
  • High bilirubin production plus immature conjugation causes physiologic jaundice [1]
  • Unconjugated bilirubin can cross the blood-brain barrier [1]
Clinical picture
  • Cephalocaudal jaundice, poor feeding or lethargy [1]
  • Jaundice in the first 24 hours, pale stools or dark urine is pathological [1]
Investigations
  • Measure serum/transcutaneous bilirubin and plot by postnatal age [2]
  • Direct bilirubin, blood group/DAT, FBC/film, reticulocytes and G6PD as indicated [2]
Management
  • Optimise feeding; use threshold-based phototherapy [3]
  • Urgent exchange transfusion for dangerous levels or acute bilirubin encephalopathy [3]
Complications
  • Acute bilirubin encephalopathy and kernicterus [4]
  • Conjugated jaundice may signal biliary atresia requiring time-critical treatment [4]
Prevention / follow-up
  • Universal predischarge assessment plus prompt follow-up [3]
  • Give parents clear feeding and jaundice safety-net advice [3]
Exam traps
  • Jaundice under 24 hours is never physiologic [2]
  • Phototherapy does not treat conjugated hyperbilirubinaemia [3]

References

[1] Paediatrics in Review - Jaundice - Newborn to Age 2 Months.pdf (p. 1)

[2] Senior notes: Adrian Lui Pediatrics Notes.pdf (pp. 46–49, 264)

[3] Senior notes: Adrian Lui Pediatrics Notes.pdf (pp. 46–49, 264)

[4] Senior notes: Adrian Lui Pediatrics Notes.pdf (pp. 46–49, 264–265)

Neonatal Jaundice (NNJ) — Definition, Epidemiology, Risk Factors, Anatomy & Physiology, Aetiology, Pathophysiology, Classification, and Clinical Features


Neonatal jaundice (NNJ) — also called icterus neonatorum — is the yellow discoloration of the skin, sclerae, and mucous membranes of a newborn infant caused by the accumulation of bilirubin in subcutaneous tissues. The word "jaundice" derives from the French jaune (yellow); "icterus" comes from the Greek ikteros (yellowness) [1][2].

  • Jaundice becomes clinically visible when total serum bilirubin (TSB) reaches approximately 80–100 µmol/L (≈ 5 mg/dL) [3][4].
  • It is important to distinguish from carotenaemia (yellow-orange skin from dietary carotene/lycopene), which spares the sclerae and mucous membranes [1][5].

Key Distinction — Conjugated vs Unconjugated

The single most important first step in evaluating any jaundiced neonate is to determine whether the hyperbilirubinaemia is unconjugated (indirect) or conjugated (direct). This dictates the entire downstream differential, investigation pathway, and urgency of referral. Conjugated hyperbilirubinaemia in a neonate is NEVER physiological and always warrants urgent investigation.


  • Present in > 50% of term and > 80% of preterm infants within the first few days of life [3][4].
  • More common in East Asians (including the Hong Kong Chinese population); Asian neonates tend to have higher peak bilirubin levels and a later peak (Day 4–5) compared with Caucasians (Day 2–4) [3][4][6].
  • Approximately 60% of healthy full-term newborns develop visible jaundice in the first week [1].
  • Severe hyperbilirubinaemia (TSB > 342 µmol/L / 20 mg/dL) occurs in a smaller subset but carries the risk of bilirubin-induced neurological dysfunction (BIND) [7].

Hong Kong Context

  • G6PD deficiency is the most common enzymopathy worldwide and is highly prevalent in Southern Chinese (estimated 4–6% of males in Hong Kong) — this is a major contributor to pathological and severe NNJ locally [3][4].
  • Universal neonatal cord-blood TSH screening is performed in Hong Kong for congenital hypothyroidism (incidence ~1:3,000 locally), which itself is a cause of prolonged unconjugated jaundice [8].
  • Biliary atresia incidence is higher in East Asians (~1 in 5,000–8,000 live births in some Asian series vs ~1 in 15,000–18,000 in Western populations) [3].

Understanding risk factors is crucial because they determine who needs closer monitoring after birth.

CategoryRisk FactorMechanism / Rationale
DemographicMale genderMales have higher daily bilirubin production
Asian ethnicityLikely genetic factors (UGT1A1 polymorphisms, higher G6PD deficiency prevalence)
Maternal age ≥ 25 yearsAssociation noted epidemiologically
GestationalPrematurity (especially GA 35–36 weeks, "late preterm")Immature hepatic conjugation (low UDPGT activity), immature gut motility → ↑ enterohepatic circulation
Gestational diabetes mellitus (GDM)Macrosomia → polycythaemia → ↑ haem turnover; also birth injury/bruising
HaematologicalBlood group incompatibility (ABO, Rh, Kell, Duffy)Immune-mediated haemolysis → ↑ bilirubin load
G6PD deficiencyOxidative stress → episodic/chronic haemolysis
Hereditary spherocytosis / other RBC membrane/enzyme defects↑ RBC fragility → haemolysis
Birth-relatedCephalhaematoma or significant bruisingExtravascular blood → breakdown of extravasated haem
Instrumental/traumatic deliverySame mechanism as above
FeedingExclusive breastfeedingSuboptimal caloric intake in early days → dehydration, ↑ enterohepatic circulation; also breast milk factors (see below)
Inadequate feeding / excessive weight loss ( > 7–10% birth weight)↓ gut motility, ↓ stool output → ↑ enterohepatic circulation
OtherPrevious sibling with significant jaundiceShared genetic/immune risk
High altitude↑ Erythropoiesis → polycythaemia
East Asian genetic polymorphisms (UGT1A16, UGT1A128)↓ UDPGT expression/activity

[3][4][6][7]


4. Anatomy, Physiology, and Normal Bilirubin Metabolism

Bilirubin is the end-product of haem catabolism. In newborns:

  • ~75% comes from the breakdown of haemoglobin in senescent or haemolysed red blood cells (RBCs).
  • ~25% comes from ineffective erythropoiesis and turnover of other haem-containing proteins (myoglobin, cytochromes, catalase).

Key enzymes and transporters: [3][4]

  1. Haem oxygenase — rate-limiting step; converts haem → biliverdin + CO + iron
  2. Biliverdin reductase — converts biliverdin → unconjugated bilirubin (UCB)
  3. Albumin — carrier protein in blood; UCB is water-insoluble so must be protein-bound
  4. Ligandin (glutathione-S-transferase) — intracellular carrier within hepatocyte
  5. UDP-glucuronosyltransferase (UDPGT / UGT1A1) — the key conjugation enzyme; adds glucuronic acid to make bilirubin water-soluble
  6. MRP2 (ABCC2) — canalicular transporter excreting conjugated bilirubin into bile
  7. β-glucuronidase — intestinal enzyme that deconjugates bilirubin → enables reabsorption (enterohepatic circulation)

Physiological jaundice arises from the convergence of THREE normal neonatal phenomena [4][6][7]:

FactorAdult vs NeonateExplanation
↑ Bilirubin productionNeonatal haematocrit is 50–60% (vs adult ~40%); fetal RBCs have a shorter lifespan (~70–90 days vs adult ~120 days)More RBCs turning over faster = more haem = more bilirubin
↓ Bilirubin clearance (conjugation)Neonatal UDPGT activity is only ~1% of adult levels at birth, reaching adult levels by ~14 weeksImmature enzyme → UCB accumulates because it cannot be conjugated efficiently
↑ Enterohepatic circulationNeonatal gut is relatively sterile (fewer bacteria to convert bilirubin to urobilinogen); gut motility is immature; feeding volumes are small in first daysConjugated bilirubin sits in the gut longer → β-glucuronidase (abundant in neonatal intestinal brush border) deconjugates it → free UCB reabsorbed into portal circulation → returns to liver → net increase in serum UCB

High Yield — Physiological Jaundice Definition Criteria

Physiological jaundice is a diagnosis of exclusion. It must satisfy ALL of the following:

  • Appears after 24 hours of age (never in the first 24h — that is always pathological!)
  • Peaks at Day 2–3 in Caucasians, Day 4–5 in Asians
  • TSB does not exceed age-specific thresholds (roughly < 200–220 µmol/L in term)
  • Rate of rise < 85 µmol/L/day (< 5 mg/dL/day)
  • Resolves within 2 weeks (term) or 3 weeks (preterm)
  • Unconjugated hyperbilirubinaemia only (conjugated bilirubin normal)
  • Baby is well, feeding well, growing appropriately
  • No evidence of haemolysis on blood film

Unlike adults (where TSB > 26 µmol/L is abnormal), neonatal bilirubin levels are interpreted against age-in-hours using a nomogram (e.g., Bhutani nomogram). There is no single "normal" TSB cutoff — it depends on postnatal age and risk zone.

  • Term neonate: TSB typically peaks at ~100–170 µmol/L (6–10 mg/dL) around Day 3–5 [7].
  • Preterm neonate: peaks may be higher (up to ~250 µmol/L) and later (Day 5–7) due to even more immature conjugation.
  • Conjugated bilirubin should always be < 17.1 µmol/L (1 mg/dL) or < 15% of TSB — exceeding this defines conjugated hyperbilirubinaemia and is always pathological [3].

5. Aetiology and Classification

5.1 Temporal Classification (The Classic Framework)

This is the most clinically useful classification for neonatal jaundice and is the framework used in the GC lecture and the HKUMed paediatric curriculum [3][4][9]:

CausePathophysiologyHong Kong Relevance
Haemolytic disorders — Blood group incompatibility (ABO, Rh, Kell, Duffy)Maternal IgG antibodies cross placenta → attack fetal/neonatal RBCs → haemolysis → massive UCB productionABO incompatibility (mother O, baby A or B) is the most common immune haemolytic cause. Rh disease is less common due to anti-D prophylaxis but still occurs.
RBC enzyme defects — especially G6PD deficiencyG6PD-deficient RBCs cannot regenerate NADPH → cannot reduce glutathione → oxidative damage → haemolysis (may be triggered by drugs, mothballs [naphthalene], fava beans, infection)Very important in HK — ~4–6% of males; X-linked recessive but female carriers can be affected. All male neonates in HK are screened for G6PD deficiency at birth via the neonatal screening programme.
RBC membrane defects — hereditary spherocytosis (HS), hereditary elliptocytosisDefective spectrin/ankyrin → spherical RBCs → trapped and destroyed in spleen → extravascular haemolysisHS is the most common inherited membrane defect in Caucasians; less common but still seen in HK
Haemoglobinopathies — α-thalassaemia (Hb Bart's hydrops fetalis)Absent α-globin chains → only γ₄ tetramers (Hb Bart's) → severe anaemia and haemolysis in uteroα-thalassaemia carrier rate is ~3–5% in Southern Chinese; homozygous α-thal major causes hydrops fetalis
Congenital infections (TORCH)Infection → haemolysis + hepatitis → both ↑ production and ↓ clearance of bilirubinCMV is the most common congenital infection globally

Key teaching point: Jaundice within the first 24 hours of life is a RED FLAG — think haemolysis until proven otherwise. [3][4][9]

CausePathophysiology
Physiological jaundiceSee Section 4.3 above — the triad of ↑ production, ↓ conjugation, ↑ enterohepatic circulation
Breastfeeding jaundice (distinct from breast milk jaundice)Inadequate intake in the first few days → dehydration, ↓ stool output → ↑ enterohepatic circulation. This is essentially an exaggeration of physiological jaundice due to poor caloric intake. Improves with adequate feeding support.
Breast milk jaundiceSubstances in breast milk (β-glucuronidase, lipase-generated free fatty acids, other unidentified factors) → inhibit UDPGT and/or promote enterohepatic circulation. Typically presents after Day 4–7, peaks at 2 weeks, and can persist for up to 12 weeks. The baby is well, thriving, and gaining weight.
Infection (especially UTI — a classic "hidden" cause of jaundice in neonates)Sepsis/infection → ↓ hepatic function + haemolysis + ↑ enterohepatic circulation
Haemolytic disorders (same as above — can present in this window too)As above
Internal haemorrhage (cephalhaematoma, subgaleal haemorrhage, IVH, adrenal haemorrhage)Extravasated blood breaks down → large haem load → ↑ UCB production
PolycythaemiaNeonatal polycythaemia (e.g., IDM, twin-to-twin transfusion, delayed cord clamping, SGA) → more RBCs to break down → ↑ bilirubin
Crigler-Najjar syndromeType I: complete absence of UDPGT (AR) — severe, life-threatening; Type II: markedly reduced UDPGT — responds to phenobarbitone

C. Prolonged / Persistent Jaundice ( > 2 weeks in term, > 3 weeks in preterm)

This is the group that demands fractionation of bilirubin (split into conjugated and unconjugated) to guide further workup.

CauseKey Points
Physiological / breastmilk jaundice (resolving)Most common cause; baby well, gaining weight
InfectionUTI in particular; always check urinalysis and culture
Hypothyroidism↓ Thyroid hormone → ↓ UDPGT activity + ↓ gut motility → ↑ enterohepatic circulation. Picked up on newborn screening (cord blood TSH in HK).
Haemolytic disordersOngoing haemolysis from any cause listed above
High GI obstruction (e.g., pyloric stenosis)Vomiting → dehydration + ↓ enteral intake → ↓ stool passage → ↑ enterohepatic circulation
Gilbert syndromeCommon (5% prevalence), usually not diagnosed until adolescence. UGT1A1 promoter polymorphism → mild ↓ conjugation. Rarely causes clinically significant neonatal jaundice alone but may compound other causes.
CauseKey Points
Biliary atresia (BA)The most important surgical cause to exclude — progressive obliterative cholangiopathy of intra- and extrahepatic bile ducts. Incidence ~1/5,000–15,000. Biliary atresia is the most common indication for paediatric liver transplantation. Presents with prolonged jaundice, pale/clay-coloured (acholic) stools, dark urine, hepatomegaly. Kasai portoenterostomy ideally before 60 days (and certainly before 12 weeks).
Choledochal cystCongenital cystic dilatation of bile ducts → obstruction → cholestasis
Neonatal hepatitis (idiopathic, viral, bacterial)Aetiological agent often unknown; giant cell transformation on biopsy
Metabolic / IEM — galactosaemia, tyrosinaemia, citrin deficiency (NICCD), α₁-antitrypsin deficiency, cystic fibrosis, neonatal haemochromatosisEach has a specific metabolic defect leading to hepatocyte dysfunction and/or cholestasis
Parenteral nutrition-associated cholestasis (PNAC)Prolonged TPN ( > 2 weeks) → cholestasis via ↓ enteral stimulation of bile flow + lipid toxicity
Syndromic — Alagille syndrome (paucity of intrahepatic bile ducts + characteristic facies + cardiac/vertebral/ocular anomalies)AR/AD depending on subtype
Inspissated bile syndromeConcentrated bile plugging ducts, especially after haemolytic disease

[3][4][6][9][10]

Exam Classic — Biliary Atresia vs Neonatal Hepatitis

A very common exam question. Both present with prolonged conjugated jaundice in a neonate. The key clinical clue is acholic (pale/clay-coloured) stools — persistently pale stools strongly suggest biliary atresia. In neonatal hepatitis, stools may be intermittently pale but often retain some pigment. The stool colour card is used in Hong Kong as a screening tool at the 1-month well-baby check. Never dismiss persistent pale stools in a jaundiced baby.

TypeBilirubin FractionKey Feature
Unconjugated (indirect) hyperbilirubinaemiaPredominantly UCB; conjugated bilirubin < 17.1 µmol/L and < 15% TSBYellow skin; normal urine colour; normal stool colour. Risk of kernicterus at very high levels.
Conjugated (direct) hyperbilirubinaemiaConjugated bilirubin > 17.1 µmol/L (1 mg/dL) or > 15% of TSBYellow-greenish skin hue; tea-coloured (dark) urine; pale/acholic stools. Does NOT cause kernicterus but indicates serious hepatobiliary disease.

[3][4]

FeaturePhysiologicalPathological
OnsetAfter 24 hoursWithin first 24 hours (always pathological) or abnormally high/prolonged
TSB levelWithin age-appropriate rangeExceeds age-specific phototherapy thresholds
Rate of rise< 85 µmol/L/day (< 5 mg/dL/day)> 85 µmol/L/day
DurationResolves by 2 weeks (term) / 3 weeks (preterm)Persists beyond these cutoffs
Conjugated fractionNormal (< 17.1 µmol/L)Elevated (if conjugated → always pathological)
Clinical stateBaby well, feeding wellUnwell, poor feeding, hepatomegaly, pale stools, dark urine

6. Pathophysiology — Specific Conditions in Detail

Already covered in Section 4.3. To summarise with a mnemonic:

Mnemonic: "PCE" — Production ↑, Conjugation ↓, Enterohepatic circulation ↑

These are frequently confused. They are two distinct entities:

Breastfeeding JaundiceBreast Milk Jaundice
TimingFirst 3–5 daysAfter Day 4–7, peaks at 2 weeks
MechanismInadequate caloric intake → dehydration, ↓ stool frequency → ↑ enterohepatic circulationSubstances in breast milk (β-glucuronidase, lipase products, pregnanediol [older theory], epidermal growth factor) that inhibit UGT1A1 or ↑ intestinal bilirubin absorption
Baby's conditionMay be dehydrated, losing weight excessively ( > 7–10% of birth weight)Well, thriving, gaining weight
ManagementImprove breastfeeding technique, increase feed frequency (8–12 times/day), consider supplementation if severe dehydrationReassurance. Continue breastfeeding. Resolves spontaneously by 3 months. If diagnostic doubt, a 24–48h trial of formula leads to rapid ↓ in TSB (but this is rarely needed and interruption of breastfeeding is generally discouraged).
TypeUnconjugatedUnconjugated

  • ABO incompatibility: Mother is blood group O (has naturally occurring anti-A and anti-B IgG) → crosses placenta → attacks fetal A or B RBCs. Usually milder than Rh disease because A and B antigens are expressed on many tissue types (not just RBCs), so antibodies are "mopped up." However, can still cause significant jaundice.
  • Rh (anti-D) incompatibility: Rh-negative mother sensitised (previous pregnancy, miscarriage, transfusion) → produces anti-D IgG → crosses placenta → severe haemolysis of Rh-positive fetal RBCs. Can cause hydrops fetalis in severe cases. Prevented by anti-D immunoglobulin prophylaxis.
  • G6PD deficiency: X-linked recessive. The enzyme G6PD is essential for the hexose monophosphate shunt (pentose phosphate pathway), which generates NADPH → needed to regenerate reduced glutathione → protects RBCs from oxidative damage. Without it, oxidative stressors (infections, drugs like sulfonamides/antimalarials, naphthalene mothballs, fava beans) cause Heinz body formation (denatured haemoglobin precipitates) → bite cells/blister cells on smear → extravascular (and sometimes intravascular) haemolysis. In neonates, G6PD deficiency can cause severe NNJ even without an identifiable trigger, likely because neonatal RBCs are inherently more susceptible to oxidative stress.

This is the feared complication of unconjugated hyperbilirubinaemia. Conjugated bilirubin does NOT cause kernicterus — instead it signals hepatobiliary disease [3].

Mechanism:

  1. When UCB levels exceed the albumin-binding capacity, free (unbound) UCB circulates.
  2. Free UCB is lipophilic → crosses the blood-brain barrier (BBB).
  3. UCB is toxic to neurons, especially in the basal ganglia (globus pallidus, subthalamic nucleus), brainstem auditory nuclei, and hippocampus.
  4. Damage occurs via mitochondrial toxicity, excitotoxicity, oxidative stress, and apoptosis.

Factors that ↑ risk of BIND:

  • Low serum albumin (preterm infants have lower albumin levels → lower binding capacity)
  • Competitive binding to albumin by drugs (e.g., sulfonamides, ceftriaxone) or free fatty acids → displaces bilirubin
  • Acidosis (↓ albumin-bilirubin binding affinity)
  • Sepsis / infection (opens BBB, ↑ bilirubin production, ↓ albumin)
  • Prematurity (immature BBB, lower albumin, greater susceptibility of developing brain)
  • Hypoalbuminaemia from any cause
  • Haemolysis (rapid ↑ in UCB can overwhelm binding capacity)

Clinical Presentation [3]:

StageSyndromeFeaturesReversibility
AcuteAcute bilirubin encephalopathy (ABE)Lethargy, hypotonia (early) → hypertonia, irritability, high-pitched cry, poor feeding (intermediate) → opisthotonos (severely arched back), retrocollis (arched neck), fever, seizures → coma and deathPotentially reversible with urgent treatment (exchange transfusion)
ChronicKernicterus (核黃疸)Dystonic cerebral palsy (choreoathetoid movements), sensorineural hearing loss (SNHL), upward gaze palsy (due to damage to vertical gaze centres in midbrain), intellectual disability, enamel dysplasia / green-brown teeth discolourationIrreversible

The word "kernicterus" literally means "kern" (nucleus, German) + "icterus" (jaundice) — referring to yellow staining of the brain nuclei (especially basal ganglia) seen at autopsy.

Ceftriaxone & Neonates

Ceftriaxone is relatively contraindicated in neonates (especially those with jaundice or hypoalbuminaemia) because it displaces bilirubin from albumin, increasing free UCB and the risk of kernicterus. Use cefotaxime as the alternative third-generation cephalosporin in neonates.

Biliary atresia is the single most important cause of conjugated neonatal jaundice to identify early because it is surgically treatable, but outcomes are time-dependent. [3][4][9][10]

  • Epidemiology: Incidence ~1/5,000–15,000 births; higher in East Asians
  • Pathophysiology: Unknown aetiology (theories include viral trigger, immune-mediated injury, genetic susceptibility). Progressive inflammatory obliterative cholangiopathy affecting both extrahepatic and intrahepatic bile ducts → complete obstruction of bile flow → cholestasis → progressive hepatic fibrosis → biliary cirrhosis → liver failure and death by age 2 years if untreated [3].
  • Two forms:
    • Isolated (perinatal) form (~85%): normal anatomy initially, progressive destruction postnatally
    • Syndromic (embryonic/fetal) form (~15%): associated with situs inversus, polysplenia, cardiac defects (laterality defects)

Clinical features of biliary atresia:

  • Prolonged conjugated jaundice (the baby looked "well" initially)
  • Acholic (clay/pale) stools — the hallmark finding; stool colour card screening used in HK
  • Dark (tea-coloured) urine — conjugated bilirubin is water-soluble and spills into urine
  • Hepatomegaly → progresses to hepatosplenomegaly (portal hypertension)
  • Poor growth / failure to thrive — impaired bile flow → ↓ fat absorption → ↓ absorption of fat-soluble vitamins (A, D, E, K)

7. Clinical Features of Neonatal Jaundice

SymptomPathophysiological Basis
Yellow discolouration of skin and eyesBilirubin deposition in subcutaneous tissues and sclerae. Visible when TSB > 80–100 µmol/L.
Poor feeding / lethargyEarly sign of bilirubin encephalopathy; also may indicate sepsis or dehydration exacerbating jaundice
High-pitched cryBilirubin neurotoxicity → brainstem irritation
Dark urine ("stains the nappy dark yellow/brown")Indicates conjugated hyperbilirubinaemia — conjugated bilirubin is water-soluble → filtered by kidneys
Pale / clay-coloured stoolsAbsence of stercobilin due to obstructed biliary excretion (biliary atresia, choledochal cyst)
Excessive weight loss / poor weight gainInadequate feeding → dehydration → ↑ enterohepatic circulation (breastfeeding jaundice); or malabsorption in cholestatic disease

Ask About Stool and Urine Colour!

Always ask about stool and urine colour in any jaundiced neonate. Dark urine + pale stools = conjugated hyperbilirubinaemia = urgent investigation needed. This is a question that is frequently tested in exams and commonly missed on the wards.

SignPathophysiological Basis
Jaundice — progresses cephalocaudally (Kramer's rule)Bilirubin deposits in skin from head → trunk → extremities → palms/soles as levels rise. Face ≈ 85 µmol/L; mid-abdomen ≈ 256 µmol/L; soles ≈ 342 µmol/L [3]
Scleral icterusBilirubin has high affinity for elastin-rich scleral tissue; best assessed under natural light
Yellow-green hueSuggests conjugated hyperbilirubinaemia (oxidised bilirubin → biliverdin gives greenish tinge)
HepatomegalyHaemolysis (extramedullary haematopoiesis), hepatitis, biliary obstruction
SplenomegalyHaemolysis (extravascular destruction in spleen); portal hypertension (biliary atresia with cirrhosis)
PallorAnaemia from haemolysis
Petechiae / bruisingCongenital infection (TORCH); also ↓ vitamin K in cholestasis (↓ fat-soluble vitamin absorption) → coagulopathy
Cephalhaematoma / bruising / swellingExtravascular blood → haem breakdown → ↑ UCB production
Hydrops fetalis (oedema, ascites, pleural effusion)Severe anaemia from Rh disease or α-thalassaemia major → high-output cardiac failure
Hypotonia → hypertonia, opisthotonos, retrocollisAcute bilirubin encephalopathy — bilirubin toxicity to basal ganglia and brainstem
Poor Moro reflex, absent suckingNeurological depression from bilirubin toxicity
Dysmorphic featuresMay suggest syndromic cause (e.g., Alagille syndrome: triangular facies, posterior embryotoxon in eye; Down syndrome associated with polycythaemia)
CataractsGalactosaemia (a metabolic cause of conjugated jaundice)
Abnormal newborn reflexes / developmental concernCongenital hypothyroidism, congenital infection

  • Always plot weight, length, and head circumference on age-appropriate growth charts.
  • Poor weight gain may indicate:
    • Inadequate feeding (breastfeeding jaundice)
    • Malabsorption (cholestatic disease — ↓ bile salts → ↓ fat and fat-soluble vitamin absorption)
    • Chronic haemolysis (↑ metabolic demand)
    • Underlying metabolic disease
  • Fat-soluble vitamin deficiencies (A, D, E, K) in cholestasis:
    • Vitamin K: coagulopathy → bleeding (can present as haemorrhagic disease of the newborn)
    • Vitamin D: rickets
    • Vitamin A: poor night vision (unlikely to be detected in neonates)
    • Vitamin E: haemolytic anaemia, neuromuscular dysfunction

  • Neonatal jaundice is extremely common and often benign — parents need reassurance but also education about warning signs (increasing jaundice, poor feeding, lethargy, pale stools, dark urine).
  • In Hong Kong, the stool colour card is given to all parents at discharge to monitor for acholic stools as a screen for biliary atresia.
  • Cultural considerations: in Chinese culture, some traditional practices (e.g., keeping the baby wrapped up, avoiding sunlight) may delay recognition of jaundice.
  • Consent/assent: In the neonatal period, all consent is obtained from parents/legal guardians. Explain phototherapy and (if needed) exchange transfusion clearly — parents often worry about "the light" and blood transfusion.

TimingUnconjugated CausesConjugated Causes
< 24 hoursHaemolytic disease (ABO, Rh, G6PD, HS, thal), congenital infection—
24h – 2 weeksPhysiological, breastfeeding jaundice, breast milk jaundice, infection (UTI), haemolysis, polycythaemia, cephalhaematoma, Crigler-Najjar— (rare at this stage)
> 2 weeks (term) / > 3 weeks (preterm)Breast milk jaundice, hypothyroidism, infection, haemolysis, pyloric stenosis, Gilbert syndromeBiliary atresia, choledochal cyst, neonatal hepatitis, metabolic (galactosaemia, tyrosinaemia, citrin deficiency, α₁-AT deficiency, CF), PNAC, Alagille syndrome, neonatal haemochromatosis, inspissated bile

High Yield Summary

  1. Neonatal jaundice is the most common clinical condition in neonates — > 50% term, > 80% preterm, higher in Asians.
  2. Physiological jaundice is due to ↑ bilirubin production (high Hct, short RBC lifespan), ↓ conjugation (immature UDPGT), and ↑ enterohepatic circulation (sterile gut, low feeding volumes). It appears after 24h, peaks Day 3–5, and resolves by 2 weeks.
  3. Jaundice < 24 hours = ALWAYS pathological → think haemolysis (ABO, Rh, G6PD).
  4. G6PD deficiency is the most important enzymopathy in Hong Kong Chinese males (~4–6%) — screened at birth.
  5. Prolonged jaundice ( > 2 weeks term / > 3 weeks preterm) → MUST fractionate bilirubin (split conjugated vs unconjugated).
  6. Conjugated hyperbilirubinaemia is NEVER physiological → urgent investigation to exclude biliary atresia (surgical emergency — Kasai before 60 days ideal).
  7. Biliary atresia is the most common indication for paediatric liver transplant. Clues: persistent acholic stools, dark urine, hepatomegaly.
  8. BIND / Kernicterus is caused by unconjugated bilirubin crossing the BBB → damages basal ganglia → acute: opisthotonos, seizures; chronic: dystonic CP, SNHL, upward gaze palsy.
  9. Ceftriaxone is avoided in jaundiced/hypoalbuminaemic neonates (displaces bilirubin from albumin).
  10. Stool colour card is used in Hong Kong to screen for biliary atresia at the 1-month check.

Active Recall - Neonatal Jaundice (Definition, Epidemiology, Pathophysiology, Clinical Features)


[1] Paediatrics in Review - Jaundice - Newborn to Age 2 Months.pdf (p. 1) [2] Ryan Ho Fundamentals.pdf (p. 295) [3] Adrian Lui Pediatrics Notes.pdf (pp. 46–48, 264) [4] MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 311) [5] Ryan Ho GI.pdf (p. 192) [6] Block C - A jaundiced child.pdf [7] Unconjugated hyperbilirubinemia in newborns ≥35 weeks of gestation: Etiology and pathogenesis - UpToDate.pdf (pp. 1, 9) [8] Block A - I am losing weight and sweating all the time: causes of severe weight loss; thyrotoxicosis; hypothyroidism.pdf (p. 41) [9] GC 146. A jaundiced child.pdf (pp. 31, 48) [10] Maksim Surgery Notes.pdf (p. 121)

Differential Diagnosis of Neonatal Jaundice


Before listing individual diseases, you must understand the logic of the differential. The single most important branch point in the entire approach to a jaundiced neonate is:

Is the hyperbilirubinaemia predominantly unconjugated (indirect) or conjugated (direct)? [3][9]

Why? Because the downstream differential, the urgency, and the feared complications are entirely different:

  • Unconjugated → risk of kernicterus (neurotoxic); most causes are benign or haematological
  • Conjugated → risk of progressive liver destruction (biliary atresia); NEVER physiological, always demands urgent workup [3][9][11]

The second branch point is timing of onset, which further narrows the differential.


2. Complete Differential Diagnosis — Organised by Timing and Bilirubin Type

CauseCategoryWhy It Causes Early Jaundice
ABO incompatibilityImmune haemolysisMother group O → has IgG anti-A/anti-B → crosses placenta → destroys fetal A/B RBCs → massive UCB load from birth [3][11][12]
Rh incompatibilityImmune haemolysisSensitised Rh-negative mother → anti-D IgG crosses placenta → severe haemolysis of Rh-positive fetal RBCs; can cause hydrops fetalis [3][12]
Other blood group incompatibility (Kell, Duffy, Kidd)Immune haemolysisSame mechanism — maternal alloantibodies attack fetal RBCs
G6PD deficiencyRBC enzyme defectNeonatal RBCs already vulnerable to oxidative stress; in severe cases jaundice begins < 24h even without a clear trigger [3][11]
Hereditary spherocytosis / elliptocytosisRBC membrane defectAbnormal cytoskeleton → splenic trapping and destruction → extravascular haemolysis from birth [14]
Pyruvate kinase deficiencyRBC enzyme defectImpaired glycolysis → ATP depletion → rigid RBCs → haemolysis
α-thalassaemia major (Hb Bart's hydrops)HaemoglobinopathyNo α-globin → only γ₄ tetramers → severe anaemia/haemolysis in utero and from birth
Congenital infection (TORCH — CMV, toxoplasma, rubella, syphilis, HSV)InfectionDirect hepatocyte damage (conjugated component) AND haemolysis → mixed picture; often < 24h [3][11]

High Yield — ABO vs Rh Incompatibility in the Neonatal Context

ABO incompatibility is the most common cause of immune haemolytic disease in neonates [12]. Key features distinguishing it from Rh disease:

  • ABO: Can occur in first pregnancy (mother already has naturally occurring anti-A/B IgG). Usually milder because A/B antigens are expressed on many tissue types → antibodies are "mopped up." Direct Coombs test may be weakly positive or negative.
  • Rh: Typically requires prior sensitisation (previous pregnancy/transfusion). More severe. Direct Coombs test is strongly positive. Hydrops fetalis possible.

CauseCategoryKey Distinguishing Feature
Physiological jaundiceNormal variantDiagnosis of exclusion [3]. Onset Day 2–3, peaks Day 4–5 (Asians), resolves by 2 weeks. Baby well, feeding well. UCB only, no haemolysis on film, normal hepatic enzymes [4][6]
Breastfeeding jaundiceFeeding-relatedInadequate intake → dehydration → ↓ stool frequency → ↑ enterohepatic circulation. Baby may be losing > 7–10% birth weight. Improves with adequate feeding [3][11][15]
Breast milk jaundiceFeeding-relatedSubstances in breast milk (β-glucuronidase, lipase products, EGF) → inhibit UDPGT / ↑ enterohepatic circulation. Baby is well and thriving — this is the key distinction from breastfeeding jaundice. Onset after Day 4–7, can persist weeks [3][11][15]
Infection (especially UTI)InfectionA "hidden" but classic cause — always check urinalysis and urine culture in any neonate with unexplained jaundice [3][11]. Mechanism: sepsis → ↓ hepatic function + haemolysis + ↑ enterohepatic circulation
Cephalhaematoma / significant bruisingExtravascular haemorrhageExtravasated blood → haem breakdown over days → ↑ UCB production [4][6]
Polycythaemia↑ RBC massMore RBCs = more haem to metabolise. Causes: infant of diabetic mother (IDM), twin-to-twin transfusion syndrome, delayed cord clamping, SGA [3][11]
Crigler-Najjar syndromeCongenital conjugation defectType I: absent UDPGT → severe UCB, risk of kernicterus, fatal without treatment; Type II: markedly reduced UDPGT → responds to phenobarbitone [3][13][16]
Haemolytic disorders (as in 2A)HaemolysisMay present in this window if milder or detected later

Important questions to ask at this stage [11]:

  • Age of onset ( < 48h, D3–7, after D7)?
  • Urine and stool colour (dark urine/pale stool → conjugated)?
  • Fever (infection)?
  • Weight change and urine output (dehydration / breastfeeding failure)?
  • Maternal blood group?
  • Birth history: gestation, cord blood screening (ABO/G6PD in HK), mode of delivery, bruising?
  • Feeding: breast vs formula, frequency, volume?
  • Family history: G6PD, jaundice, anaemia, splenectomy, liver disease?

2C. Prolonged / Persistent Jaundice ( > 2 weeks term, > 3 weeks preterm)

This is where the fractionation of bilirubin becomes absolutely critical because the differential splits completely.

CauseWhy Prolonged?Key Clinical Clue
Breast milk jaundiceOngoing inhibition of conjugation by breast milk components; can last up to 12 weeksBaby well, thriving, gaining weight — most common cause of prolonged unconjugated jaundice [3][11]
Hypothyroidism↓ Thyroid hormone → ↓ UDPGT activity + ↓ gut motility → ↑ enterohepatic circulationShould be picked up on neonatal cord blood TSH screening (done in HK). Other clues: prolonged jaundice, constipation, macroglossia, umbilical hernia, poor feeding, hypotonia [3][8]
InfectionUTI, late-onset sepsis → ongoing haemolysis + hepatic dysfunctionFever, irritability, poor feeding; UTI may be occult — must check urine [3][11]
Ongoing haemolytic disordersContinued RBC destruction → persistent UCB loadAnaemia, reticulocytosis, splenomegaly
High GI obstruction (e.g., pyloric stenosis)Vomiting → dehydration + ↓ enteral intake → ↓ stool passage → ↑ enterohepatic circulationTypically presents at 2–8 weeks with projectile, non-bilious vomiting, visible peristalsis, palpable olive [3]
Gilbert syndrome↓ UGT1A1 expression (promoter polymorphism, AD/AR)Usually not clinically apparent until adolescence, but can compound other causes of NNJ in neonatal period. Mild isolated UCB elevation ( < 100 µmol/L) [13][16]
CauseMechanismKey Features / HK Relevance
Biliary atresia (BA)Progressive obliterative cholangiopathy → complete obstruction → fibrosis → cirrhosis → death < 2 years if untreated [3][10]Most important diagnosis to exclude in prolonged conjugated jaundice. Acholic stools, dark urine, hepatomegaly. Biliary atresia is the most common indication for paediatric liver transplant [3]. Kasai portoenterostomy ideally before 60 days [10]
Choledochal cystCongenital cystic/fusiform dilatation of bile ducts → obstruction → cholestasis [10]May mimic BA; diagnosed on USG/MRCP. Treatment: complete cyst excision + Roux-en-Y hepaticojejunostomy [10]
Neonatal hepatitis syndromeIdiopathic (most common) or secondary to viral/bacterial infection → hepatocyte injury → giant cell transformation → cholestasis [3][15]Aetiological agent unknown in majority; stools may be intermittently pale (cf. persistently pale in BA)
Metabolic / IEM:
— GalactosaemiaDeficiency of galactose-1-phosphate uridylyltransferase → toxic galactose-1-phosphate accumulates in liver, brain, kidneysVomiting, poor feeding, hepatomegaly, cataracts, E. coli sepsis. Reducing substances in urine.
— Tyrosinaemia type 1Fumarylacetoacetate hydrolase deficiency → accumulation of toxic metabolites → hepatocyte necrosisLiver failure, renal tubular dysfunction, cabbage-like odour
— Citrin deficiency (NICCD)Citrin (mitochondrial aspartate-glutamate carrier) defect → impaired urea cycle and gluconeogenesis in liverImportant in East Asian populations (common in Japanese and Chinese) — fatty liver, cholestasis, low birth weight
— α₁-antitrypsin deficiencyMisfolded α₁-AT protein accumulates in hepatocyte ER → hepatocyte injury → cholestasis/cirrhosisPiZZ phenotype; also causes emphysema in adults
— Cystic fibrosisInspissated secretions block intrahepatic bile ducts → cholestasis; also pancreatic insufficiencyRare in Chinese (much more common in Caucasians); meconium ileus, steatorrhoea
— Neonatal haemochromatosis (gestational alloimmune liver disease, GALD)Maternal alloantibodies against fetal hepatocyte antigens → complement-mediated hepatocyte destruction in utero → severe liver failure + extrahepatic siderosisVery severe — presents as neonatal liver failure; ferritin massively elevated; lip biopsy shows siderosis of minor salivary glands
Parenteral nutrition-associated cholestasis (PNAC)Prolonged TPN → ↓ enteral stimulation → ↓ bile flow; lipid component directly toxic to hepatocytesPreterm infants on prolonged TPN ( > 2 weeks); incidence declining with fish-oil based lipid emulsions [15]
Alagille syndromeMutations in JAG1/NOTCH2 → paucity of intrahepatic bile ductsCharacteristic facies (triangular face, broad forehead, pointed chin), posterior embryotoxon (eye), butterfly vertebrae, peripheral pulmonary stenosis [3]
Inspissated bile syndromeConcentrated bile plugs ducts; often follows haemolytic disease (high bilirubin load)History of severe haemolysis; resolves as bilirubin load decreases
Bile acid synthesis defectsDeficiency of enzymes for primary bile acid synthesis → toxic bile acid intermediates accumulate → cholestasisRespond to oral cholic acid therapy
Progressive familial intrahepatic cholestasis (PFIC) types 1–3Defects in bile acid/phospholipid transporters (FIC1, BSEP, MDR3) → cholestasisLow GGT in PFIC1/2 (important distinguishing feature from biliary atresia which has high GGT); high GGT in PFIC3
Dubin-Johnson syndrome / Rotor syndromeDefective canalicular excretion (DJS: MRP2 mutation) or defective hepatocyte storage (Rotor) of conjugated bilirubinBoth benign; isolated conjugated hyperbilirubinaemia with otherwise normal LFT. DJS: grossly black liver on biopsy. Rare in neonates. [13][16]

[3][10][11][15]


An alternative way to organise the same information — useful for understanding "why":

MechanismExamplesBilirubin Type
↑ Bilirubin production (haemolysis, extravasation, polycythaemia)ABO/Rh incompatibility, G6PD, HS, PKD, thalassaemia, cephalhaematoma, polycythaemia (IDM), DICUnconjugated
↓ Hepatic uptakeDrugs (rifampicin — rare in neonates), Gilbert syndrome, hypothyroidismUnconjugated
↓ ConjugationPhysiological (immature UDPGT), Crigler-Najjar I/II, Gilbert, hypothyroidism, breast milk jaundiceUnconjugated
↑ Enterohepatic circulationBreastfeeding jaundice (↓ feeding), breast milk jaundice (β-glucuronidase), pyloric stenosis, any cause of ileus/↓ gut motilityUnconjugated
↓ Canalicular excretionDubin-Johnson syndrome, PFIC, drugsConjugated
Bile duct obstruction (extrahepatic)Biliary atresia, choledochal cyst, inspissated bileConjugated
Intrahepatic cholestasis / hepatocyte damageNeonatal hepatitis, metabolic (galactosaemia, tyrosinaemia, citrin deficiency, α₁-AT def), PNAC, Alagille, GALDConjugated
MixedCongenital infection (TORCH) — both haemolysis and hepatitis; sepsisBoth

[3][15]


4. Distinguishing Key "Look-Alike" Differentials

This is the most classic and important paediatric exam differential [3][9][10].

FeatureBiliary AtresiaNeonatal Hepatitis
Stool colourPersistently acholic (pale/clay-coloured)Intermittently pale but often pigmented
GGT↑↑↑ (very high)Mildly elevated or normal
USG abdomenContracted or absent gallbladder; triangular cord sign [10]Normal/enlarged gallbladder
EHIDA scan (cholescintigraphy)No excretion into intestine (even after 5 days phenobarbitone pre-treatment)Delayed but eventually some excretion seen [14]
Liver biopsyBile duct proliferation, bile plugs, portal fibrosis (features of extrahepatic biliary obstruction)Giant cell transformation, lobular disarray, minimal bile duct proliferation
Operative cholangiogramGold standard — fails to outline normal biliary tree [10]Normal biliary anatomy
UrgencySurgical emergency — Kasai before 60 daysMedical management; most self-limiting

GC 146 Take Home Message — Causes of Conjugated Hyperbilirubinaemia and Biliary Atresia

The GC lecture (GC 146) explicitly lists as high-yield take-home messages:

  • Causes of conjugated hyperbilirubinaemia in the neonatal period
  • Biliary atresia — its recognition, investigation, and the time-critical nature of Kasai portoenterostomy

These are very likely to appear on in-house summative exams. [9]

FeatureBreastfeeding JaundiceBreast Milk Jaundice
TimingFirst 3–5 daysAfter Day 4–7, peaks at 2 weeks, may persist 12 weeks
MechanismInadequate caloric intake → dehydration → ↑ enterohepatic circulation [3][11]Breast milk substances (β-glucuronidase, lipase-generated FFAs, EGF) inhibit UDPGT or ↑ intestinal bilirubin absorption [3][11][15]
Baby's conditionMay be dehydrated, losing weightWell, thriving, gaining weight
ManagementImprove feeding technique, increase frequency (8–12×/day), supplement if severe dehydrationReassurance; continue breastfeeding [3]

Physiological jaundice is a diagnosis of EXCLUSION [3]. The following features make it pathological:

Red FlagImplies
Onset < 24 hoursHaemolysis
Rate of rise > 85 µmol/L/day ( > 5 mg/dL/day)Overwhelming bilirubin production (haemolysis)
TSB exceeds age-specific phototherapy thresholdRisk of BIND
Persists > 2 weeks (term) / > 3 weeks (preterm)Need to fractionate bilirubin
Any conjugated bilirubin elevationHepatobiliary disease
Unwell baby, poor feeding, hepatomegaly, pale stoolsInfection, cholestasis

ConditionHK Relevance
G6PD deficiency~4–6% of males; X-linked; all male neonates screened at birth via cord blood in HK. Triggers locally include mothballs (naphthalene — still used in some households), fava beans, and traditional Chinese medicines. [3][11]
α/β-thalassaemia traitα-thal carrier rate 3–5% in Southern Chinese; β-thal carrier rate ~2%. Usually NOT a cause of significant NNJ (carrier state), but severe forms (Hb Bart's hydrops, β-thal major) cause haemolysis.
Biliary atresiaHigher incidence in East Asians. Hong Kong uses the stool colour card at the 1-month well-baby check to screen for acholic stools.
Congenital hypothyroidismIncidence ~1:3,000 in HK; screened by cord blood TSH [8]. If missed → prolonged jaundice + developmental delay (cretinism).
Citrin deficiency (NICCD)Relatively common IEM in East Asians (estimated carrier rate ~1:65 in Chinese). Presents with neonatal cholestasis, fatty liver, failure to thrive.
HBV vertical transmissionHK has high HBV endemicity. Perinatal HBV transmission from HBsAg-positive mothers can cause neonatal hepatitis → conjugated jaundice. Universal HBV vaccination + HBIG given at birth.

TimingUnconjugated CausesConjugated Causes
< 24hABO/Rh/other blood group incompatibility, G6PD deficiency, hereditary spherocytosis, α-thal major, PKD, congenital infection (may also have conjugated component)Congenital infection (mixed)
24h – 2 weeksPhysiological jaundice, breastfeeding jaundice, breast milk jaundice, infection (UTI), haemolysis, cephalhaematoma, polycythaemia, Crigler-NajjarUncommon at this stage; consider congenital infection, GALD
> 2 weeks term / > 3 weeks pretermBreast milk jaundice, hypothyroidism, infection, ongoing haemolysis, pyloric stenosis, Gilbert syndromeBiliary atresia, choledochal cyst, neonatal hepatitis, metabolic/IEM (galactosaemia, tyrosinaemia, citrin deficiency, α₁-AT deficiency, CF), PNAC, Alagille, PFIC, inspissated bile, Dubin-Johnson/Rotor, bile acid synthesis defects

[3][4][6][9][10][11][15]


High Yield Summary — Differential Diagnosis of Neonatal Jaundice

  1. First step: fractionate bilirubin → unconjugated vs conjugated. This dictates the entire differential.
  2. Second step: timing → early ( < 24h), normal (24h–2w), or prolonged ( > 2w term / > 3w preterm).
  3. Jaundice < 24 hours = haemolysis until proven otherwise (ABO > Rh > G6PD > membrane defects > congenital infection).
  4. Physiological jaundice is a diagnosis of EXCLUSION — must rule out pathological causes first.
  5. Breastfeeding jaundice ≠ breast milk jaundice: the former = inadequate intake (baby losing weight); the latter = breast milk substances inhibiting conjugation (baby thriving).
  6. Prolonged conjugated jaundice → MUST exclude biliary atresia — it is surgically treatable but time-critical (Kasai before 60 days). Acholic stools are the key clue.
  7. Biliary atresia vs neonatal hepatitis: persistent acholic stools + very high GGT + contracted GB on USG + no intestinal excretion on EHIDA → biliary atresia. Confirmed by operative cholangiogram (gold standard).
  8. HK-specific: G6PD screening at birth (cord blood), congenital hypothyroidism screening (cord TSH), stool colour card at 1-month check for biliary atresia, citrin deficiency is relatively common in Chinese.
  9. Conjugated bilirubin does NOT cause kernicterus — but signals serious hepatobiliary disease.
  10. UTI is an easily missed cause of neonatal jaundice — always check urine in any unexplained jaundice.

Active Recall — Differential Diagnosis of Neonatal Jaundice

References

[3] Senior notes: Adrian Lui Pediatrics Notes.pdf (pp. 46–48, 264) [4] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 311) [6] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p. 666) [8] Senior notes: Block A - I am losing weight and sweating all the time: causes of severe weight loss; thyrotoxicosis; hypothyroidism.pdf (p. 41) [9] Lecture slides: GC 146. A jaundiced child.pdf (p. 48) [10] Senior notes: Maksim Surgery Notes.pdf (pp. 121, 333) [11] Senior notes: Maksim Paediatric Notes.pdf (p. 8) [12] Senior notes: Block A - Family history of anaemia: inherited causes of anaemia; haemolytic anaemia; aplastic anaemia.pdf (p. 3) [13] Senior notes: Ryan Ho GI.pdf (pp. 191–192, 292) [14] Senior notes: Ryan Ho Haemtology.pdf (p. 38) [15] Paediatrics in Review - Jaundice - Newborn to Age 2 Months.pdf (pp. 3, 7–8) [16] Senior notes: Maksim Medicine Notes.pdf (pp. 121, 150)

Diagnostic Criteria, Diagnostic Algorithm, and Investigation Modalities for Neonatal Jaundice


1. Defining Thresholds and Diagnostic Criteria

Unlike many medical conditions, neonatal jaundice does not have a single "diagnostic criterion" in the traditional sense. Instead, we work with age-specific thresholds and a set of criteria that distinguish physiological from pathological jaundice, and unconjugated from conjugated hyperbilirubinaemia.

  • Jaundice becomes clinically visible when TSB reaches approximately 80–100 µmol/L (≈ 5 mg/dL) [3][15].
  • Visual assessment alone is unreliable, especially in infants with darker skin tones — always confirm with measurement [3][15].

Physiological jaundice is a diagnosis of exclusion — you make it only after ruling out pathological causes [3][4]. All of the following must be met:

CriterionRationale
Onset after 24 hours of ageJaundice < 24h = haemolysis until proven otherwise
Peaks Day 2–3 (Caucasians) or Day 4–5 (Asians) [4][6]Expected timing of physiological bilirubin peak
TSB within age-specific normal range (typically < 200–220 µmol/L / 12 mg/dL in term)Exceeding threshold → pathological
Rate of rise < 85 µmol/L/day ( < 5 mg/dL/day)Rapid rise implies overwhelming production (haemolysis)
Resolves within 2 weeks (term) or 3 weeks (preterm)Persistence → requires bilirubin fractionation
Unconjugated hyperbilirubinaemia only — conjugated fraction normalAny conjugated elevation = hepatobiliary pathology
Normal hepatic enzymes (parenchymal and ductal) [4][6]Elevated enzymes suggest hepatitis or obstruction
No evidence of haemolysis on peripheral blood smear [4][6]Spherocytes, fragments, polychromasia absent
Baby is well, feeding well, growing appropriatelyUnwell baby = investigate further

Conjugated (direct) hyperbilirubinaemia is defined as: [3]

Direct bilirubin > 17.1 µmol/L (1 mg/dL) OR > 15% of TSB

This is NEVER physiological and always mandates urgent investigation to exclude surgically treatable causes (especially biliary atresia) [3][9].

GC 146 High Yield — Conjugated Hyperbilirubinaemia in Neonatal Period

The GC 146 lecture explicitly states as a take-home message: "Causes of conjugated hyperbilirubinemia in neonatal period" and "Biliary atresia". In the neonatal period, the priority with conjugated hyperbilirubinaemia is to RULE OUT obstructive jaundice amendable to surgical treatment — biliary atresia and choledochal cyst [9].

Any ONE of the following makes jaundice pathological and warrants investigation [3][4][15]:

  1. Onset < 24 hours
  2. Rate of rise > 85 µmol/L/day ( > 5 mg/dL/day)
  3. TSB exceeds age-specific phototherapy threshold (Bhutani nomogram / AAP 2022 guidelines)
  4. Prolonged: > 2 weeks (term) or > 3 weeks (preterm)
  5. Any conjugated bilirubin elevation
  6. Signs of bilirubin encephalopathy (lethargy, hypotonia, poor feeding, high-pitched cry)
  7. Unwell baby (fever, hepatomegaly, pale stools, dark urine)

All term or near-term newborns (≥ 35 weeks GA) are screened using an hour-specific total serum or transcutaneous bilirubin nomogram [15].

  • The Bhutani nomogram plots TSB against postnatal age in hours and categorises risk:
    • Low-risk zone ( < 40th percentile)
    • Low-intermediate zone (40th–75th percentile)
    • High-intermediate zone (75th–95th percentile)
    • High-risk zone ( > 95th percentile) → requires close follow-up and likely intervention

The nomogram is not designed for infants with active haemolysis or those requiring intensive care — these babies need individualised management [15].

The AAP 2022 revised guidelines (updated from the 2004 version) now use a more granular risk-based approach incorporating neurotoxicity risk factors (gestational age, albumin level, haemolytic disease, clinical instability) to set phototherapy and exchange transfusion thresholds.



4. Investigation Modalities — Detailed Breakdown

InvestigationTechniqueKey Findings & Interpretation
Transcutaneous bilirubinometer (TcB)Non-invasive optical device applied to forehead + sternum; measures skin bilirubin by spectral reflectance [3]Screening tool — usually two readings (forehead + sternum) [3]. If elevated → confirm with serum TSB. Less reliable after phototherapy (blanches skin) or in very dark/very light skin.
Visual assessment (Kramer's rule)Inspect under natural light, pressing skin ("blanching")Cephalocaudal progression: face ≈ 85 µmol/L → mid-abdomen ≈ 256 µmol/L → soles ≈ 342 µmol/L [3]. Unreliable for precise levels — always confirm with TcB or TSB.
Stool colour cardParents compare baby's stool to standardised colour card (used in HK at 1-month check)Persistent acholic (pale/clay) stools = biliary obstruction until proven otherwise — urgent referral for biliary atresia workup [9][15]
Urine inspectionDark/tea-coloured urineIndicates conjugated hyperbilirubinaemia (water-soluble conjugated bilirubin excreted by kidneys) [10][16]

TestWhat It Tells YouKey Findings
Total serum bilirubin (TSB) — direct + indirect [3]The definitive bilirubin measurement; fractionate into conjugated (direct) and unconjugated (indirect)Plot on Bhutani nomogram for risk zone. Direct bilirubin > 17.1 µmol/L or > 15% TSB = conjugated hyperbilirubinaemia [3]. Aim to intervene before TSB reaches risky levels ( < 340 µmol/L / 20 mg/dL in term; lower threshold in preterm) [3].
CBC with peripheral blood smear (PBS)Evaluate for anaemia, haemolysis, infectionAnaemia + reticulocytosis + polychromasia = haemolysis. Spherocytes (HS or ABO). RBC fragments (DIC/microangiopathic). Nucleated RBCs (severe haemolysis/stress). Leucocytosis (infection). Thrombocytopenia (DIC, congenital infection, sepsis, hypersplenism) [12][14][15]
Reticulocyte countActive bone marrow response to RBC destruction↑ Reticulocytes = haemolysis or blood loss. Expected in immune haemolysis, G6PD crisis, HS.
Blood group (mother and baby) + Direct Coombs test (DAT) [3][15]Identify immune haemolysisPositive DAT = antibodies on baby's RBCs (ABO or Rh incompatibility). Mother group O + baby A/B = ABO incompatibility. Mother Rh-negative + baby Rh-positive = Rh disease. Note: DAT may be weakly positive or even negative in ABO incompatibility (unlike Rh). [12]
G6PD assay (cord blood or neonatal screen)Identify G6PD deficiencyLow/absent G6PD activity = G6PD deficiency. All male neonates in HK are screened at birth. Caution: G6PD levels may be falsely normal during acute haemolysis (reticulocytes have higher G6PD activity) — repeat when stable if high clinical suspicion. [3]
Cord blood TFT (TSH screening)Screen for congenital hypothyroidismTSH > 7 mIU/L with fT4 < 12 pmol/L at 2 weeks = suspicious for congenital hypothyroidism → cause of prolonged unconjugated jaundice [3][8]

High Yield — Haemolysis Markers

Markers of haemolysis in neonatal jaundice [3][12]:

  • ↑ Unconjugated bilirubin
  • ↑ LDH — a quick marker; "if LDH is high, think high turnover / haemolysis" [12]
  • ↓ Haptoglobin — consumed binding free haemoglobin (may be unreliable in neonates as baseline is low)
  • ↑ Reticulocyte count — bone marrow compensation
  • ↑ Methaemalbumin — when haptoglobin is exhausted, free haem binds albumin [3]
  • ↑ AST (released from RBCs during haemolysis — AST is less liver-specific than ALT) [15]
  • PBS: polychromasia, spherocytes, fragments depending on cause

This is a separate and urgent investigation pathway triggered whenever conjugated bilirubin is elevated [9][15][17].

GC 157 (Paediatric Chemical Pathology) lists "First-line investigations of neonatal cholestasis" — this is high-yield exam content [17].

TestPurposeKey Findings & Interpretation
LFT — full panelAssess hepatocellular injury and ductal obstruction↑ Conjugated bilirubin (by definition). ↑ GGT — very important: markedly elevated GGT suggests biliary atresia, while normal/low GGT in cholestasis suggests PFIC type 1 or 2 [15]. ↑ ALP (note: neonatal ALP is physiologically higher due to bone isoenzyme — confirm hepatic origin by checking GGT [18][19]). ↑ ALT/AST = hepatocellular injury component.
Coagulation profile (PT/INR)Assess hepatic synthetic function; detect vitamin K deficiencyProlonged PT/INR may be due to: (1) cholestasis → ↓ bile salt secretion → ↓ fat-soluble vitamin K absorption → ↓ factors II, VII, IX, X (responsive to parenteral vitamin K), OR (2) hepatocellular failure (unresponsive to vitamin K) [15][16]. Distinguish by giving IV vitamin K and re-checking PT in 24h.
AlbuminHepatic synthetic function↓ Albumin = impaired synthesis (subacute/chronic liver disease)
Blood glucoseHepatic metabolic functionHypoglycaemia in acute liver failure or certain IEMs (galactosaemia)
Ammonia (NH₃)Hepatic detoxification function↑ NH₃ = liver failure or urea cycle defect
Fasting USG abdomenFirst-line imaging for biliary anatomyBiliary atresia: contracted or absent gallbladder, triangular cord sign (echogenic fibrous remnant at porta hepatis), hepatomegaly. Choledochal cyst: cystic dilatation of bile duct. Normal gallbladder does NOT exclude BA (may occasionally be seen) [3][10].
Urine (dipstick + culture)Rule out UTI — a common occult cause of jaundice in neonatesUTI can cause both unconjugated and conjugated jaundice; always perform in any neonate with unexplained jaundice
TORCH screen (serology + urine CMV PCR)Congenital infection workupCMV (urine PCR is gold standard in first 3 weeks), toxoplasma IgM, rubella IgM, HSV PCR
Newborn metabolic screen reviewIEM detectionReview results of the dried blood spot newborn screening programme (includes amino acids, acylcarnitines, thyroid function)

TestTechniqueKey Findings & Interpretation
Hepatobiliary scintigraphy (EHIDA / HIDA scan) [14][15]Pre-treatment with phenobarbitone 5 mg/kg PO × 5 days (to induce hepatic enzymes and ↑ biliary secretion) → inject ⁹⁹ᵐTc-mebrofenin IV → dynamic anterior abdominal imaging for 60 minutes, with delayed images at 4–24h [14]Biliary atresia: no excretion of isotope into intestine even on delayed images (high sensitivity ~100%, but specificity only ~60–70% — hence it is a good "rule-out" test rather than confirmatory) [15]. Neonatal hepatitis: delayed but eventually some intestinal excretion seen.
Liver biopsy (percutaneous, typically at 4–6 weeks of age)Histological assessmentBiliary atresia: bile duct proliferation, bile plugs in ductules, portal tract expansion/fibrosis (features of extrahepatic biliary obstruction) [3]. Neonatal hepatitis: giant cell transformation, lobular disarray, minimal duct proliferation. α₁-AT deficiency: PAS-positive, diastase-resistant globules in hepatocytes. Alagille: paucity of interlobular bile ducts. Should be performed at 4–6 weeks to avoid delays in surgical intervention if BA is suspected [15].
Operative (intraoperative) cholangiogramGold standard for biliary atresia — performed at laparoscopy/laparotomy; contrast injected into gallbladderFails to outline normal biliary tree in BA (contrast does not pass into intrahepatic ducts or duodenum) → proceed directly to Kasai portoenterostomy [3][10].
MRCPMRI of biliary tree — non-invasive but requires GA in neonatesCan delineate biliary anatomy, detect choledochal cyst; T2-weighted MRI may show siderosis in GALD [15]. Less reliable in very small infants.
ERCPEndoscopic assessment of biliary tree — technically very challenging in neonatesReserved for therapeutic need (e.g., biliary irrigation, sphincterotomy for sludge/stones). Requires GA. [15]

GC 146 + GC 157 — Biliary Atresia Investigation Pathway

From the GC slides, the investigation pathway for suspected biliary atresia is:

  1. LFT: ↑ conjugated bilirubin, ↑ GGT (obstructive pattern) [3]
  2. Fasting USG abdomen: contracted/absent gallbladder, triangular cord sign [10]
  3. EHIDA scan: no excretion into intestine (after 5-day phenobarbitone pre-treatment) [14]
  4. Liver biopsy: features of extrahepatic biliary obstruction [3]
  5. Operative cholangiogram: gold standard — fails to outline normal biliary tree [3][10]

TestTarget Condition
Urine reducing substances (Clinitest, NOT dipstick)Galactosaemia — positive for galactose (note: dipstick only detects glucose, NOT galactose)
Plasma amino acidsTyrosinaemia (↑ tyrosine), citrullinaemia/citrin deficiency (↑ citrulline)
Urine organic acidsOrganic acidaemias, tyrosinaemia (↑ succinylacetone)
Acylcarnitine profile (dried blood spot)Fatty acid oxidation defects, organic acidaemias [20][21]
Serum α₁-antitrypsin level + phenotypingα₁-AT deficiency (PiZZ phenotype)
Sweat chloride testCystic fibrosis (rare in Chinese but must consider)
Serum ferritin + lip biopsy (minor salivary gland iron stain)Neonatal haemochromatosis / GALD
Plasma bile acidsBile acid synthesis defects (elevated atypical bile acids)
Genetic testing (targeted or whole exome sequencing)Alagille (JAG1/NOTCH2), PFIC (ATP8B1, ABCB11, ABCB4), citrin deficiency (SLC25A13), etc.

[15][17][20][21]


ConsiderationExplanation
Normal neonatal GGT values may be 5–8× adult levelsDo not diagnose cholestasis on GGT alone — interpret in context of conjugated bilirubin and clinical picture [15]
ALP is physiologically elevated in neonates and children (due to bone isoenzyme from growth)Confirm hepatic origin by checking GGT — if both ALP and GGT are elevated → ductal pathology [18][19]
Neonatal haematological normals differ from adultsHb 14–22 g/dL, Hct 50–60%, MCV 95–115 fL at birth. Reticulocyte count normally 3–7% in first 3 days (higher than adults). Always use age-specific reference ranges.
G6PD assay timingMay be falsely normal during acute haemolysis (reticulocytes have higher G6PD) — repeat when stable
Liver biopsy timingTypically performed at 4–6 weeks of age [15] to allow time for initial workup but avoid delaying surgery for BA
ConsentAll investigations in neonates require parental/guardian consent. Explain clearly why blood tests, ultrasound, or liver biopsy are needed. For operative cholangiogram — this is performed under GA at laparoscopy, with consent for possible Kasai procedure at the same sitting.

PatternKey LFT ChangesInterpretation
Pre-hepatic (haemolysis)↑ Unconjugated bilirubin, normal ALT/AST (unless severe), normal ALP/GGT, normal albuminRBC destruction → excess bilirubin production overwhelms conjugation capacity [13][16]
Hepatocellular (hepatitis)↑ Conjugated bilirubin, ↑↑↑ ALT/AST, mildly ↑ ALP/GGT, ↓ albumin (if subacute), ↑ PT/INRHepatocyte injury → leakage of intracellular enzymes + impaired synthetic and excretory function [13][19]
Obstructive / cholestatic↑ Conjugated bilirubin, mildly ↑ ALT/AST, ↑↑↑ ALP and GGT, normal albumin (initially)Bile duct obstruction → back-pressure → ductal enzyme induction and leakage. This is the pattern of biliary atresia [3][13][19]

Key exam point: In neonates, a falling ALT/AST can mean recovery, BUT if PT/INR is simultaneously worsening → suspect fulminant hepatic failure (massive hepatocyte necrosis with few viable cells left to release enzymes) [15].


The van den Bergh reaction is a colorimetric test using sulfanilic acid (diazo reagent) that reacts with bilirubin to form a purple azobilirubin [3]:

ResultMechanismInterpretation
Direct positive — turns purple immediatelyConjugated (water-soluble) bilirubin reacts directly with reagent without added alcoholObstructive / cholestatic jaundice
Indirect positive — turns purple only after alcohol additionUnconjugated (lipid-soluble) bilirubin requires alcohol to dissolve before it can reactHaemolytic / pre-hepatic jaundice
Biphasic — turns purple immediately AND intensifies with alcoholBoth conjugated and unconjugated fractions presentHepatic jaundice (mixed)

While largely replaced by automated fractionation, this is still tested in exams.


High Yield Summary — Diagnostic Approach to Neonatal Jaundice

  1. Step 1 — Screen: TcB (non-invasive) → if elevated, confirm with serum TSB → plot on Bhutani nomogram.
  2. Step 2 — Fractionate: Always determine conjugated vs unconjugated bilirubin. This is THE branch point.
  3. Step 3 — Unconjugated pathway: CBC, PBS, reticulocyte count, blood group + Coombs test, G6PD assay, LDH. Looking for haemolysis.
  4. Step 4 — Conjugated pathway (cholestasis): Full LFT (especially GGT), coagulation profile, albumin, glucose, USG abdomen, urine culture, TORCH screen, metabolic screen. Looking for biliary atresia, neonatal hepatitis, IEM.
  5. Step 5 — Biliary atresia workup: Fasting USG (contracted GB, triangular cord sign) → EHIDA scan (no intestinal excretion after phenobarbitone pre-treatment) → liver biopsy (bile duct proliferation, portal fibrosis) → operative cholangiogram (gold standard).
  6. Step 6 — Prolonged jaundice ( > 2 weeks term / > 3 weeks preterm): MUST fractionate bilirubin. If unconjugated → check TFT, urine culture, feeding adequacy. If conjugated → cholestasis pathway (as above).
  7. Physiological jaundice = diagnosis of exclusion. Unconjugated only, normal enzymes, no haemolysis, well baby, resolves by 2 weeks.
  8. Conjugated hyperbilirubinaemia is NEVER physiological → always warrants urgent investigation.
  9. In HK: cord blood G6PD screen (males), cord TSH screen, stool colour card at 1 month.

Active Recall — Diagnostic Criteria, Algorithm, and Investigations for Neonatal Jaundice

References

[3] Senior notes: Adrian Lui Pediatrics Notes.pdf (pp. 46–49, 264) [4] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (pp. 311, 313) [6] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p. 666) [8] Senior notes: Block A - I am losing weight and sweating all the time: causes of severe weight loss; thyrotoxicosis; hypothyroidism.pdf (p. 41) [9] Lecture slides: GC 146. A jaundiced child.pdf (pp. 35, 48) [10] Senior notes: Maksim Surgery Notes.pdf (pp. 121, 333) [12] Senior notes: Block A - Family history of anaemia: inherited causes of anaemia; haemolytic anaemia; aplastic anaemia.pdf (pp. 3–4) [13] Senior notes: Ryan Ho GI.pdf (pp. 191, 193) [14] Senior notes: Ryan Ho Diagnostic Radiology.pdf (p. 64) [15] Paediatrics in Review - Jaundice - Newborn to Age 2 Months.pdf (pp. 1, 3–4, 7–9) [16] Senior notes: Maksim Medicine Notes.pdf (pp. 119, 121) [17] Lecture slides: GC 157. Paediatric Chemical Pathology.pdf (p. 6) [18] Senior notes: Block A - Introduction to GI/Hepatology investigations (LFT, Endoscopy).pdf (pp. 9–10) [19] Senior notes: Learning_Points_All_Lectures.txt (Section 1) [20] Senior notes: Ryan Ho Chemical Path.pdf (p. 56) [21] Lecture slides: Chemical Pathology Seminar_Inherited metabolic disease 2025.pdf (p. 13)

Management Algorithm and Treatment Modalities for Neonatal Jaundice


The management of neonatal jaundice is not a "one-size-fits-all" approach. It depends on:

  1. Is the jaundice unconjugated or conjugated? — Entirely different management pathways.
  2. What is the underlying cause? — Treat the cause when identifiable.
  3. How high is the bilirubin and how fast is it rising? — Determines urgency of intervention.
  4. What is the gestational age and postnatal age? — Thresholds are lower in preterm and younger neonates.
  5. Are there neurotoxicity risk factors? — These lower the threshold for treatment.

The overarching goals are [3][7][15]:

  • Prevent bilirubin-induced neurological dysfunction (BIND) / kernicterus — the feared complication of unconjugated hyperbilirubinaemia
  • Identify and treat the underlying cause (especially surgically treatable conjugated causes like biliary atresia)
  • Support feeding and nutrition
  • Communicate clearly with parents — family-centred care is paramount


3. Management of Unconjugated Hyperbilirubinaemia

MeasureRationaleDetails
Optimise feeding↑ Enteral intake → ↑ gut motility → ↑ stool output → ↓ enterohepatic circulation → ↓ bilirubin reabsorption [7][15]Breastfeed 8–12 times/day. If breastfeeding inadequate (excess weight loss > 7–10% birth weight), consider supplemental expressed breast milk or formula. Do NOT stop breastfeeding for breast milk jaundice — continue and reassure [3][6].
Adequate hydrationDehydration concentrates bilirubin and reduces gut transitAssess hydration by urine output (at least 6 wet nappies/day by Day 4), weight trajectory, and clinical exam
Monitor bilirubinTrack trajectory — is it rising, stable, or falling?Serial TcB or TSB plotted on nomogram. Frequency depends on risk zone (Q6–24h)
Parent educationFamily-centred care — empower parents to recognise warning signsExplain jaundice, its usual benign course, when to seek help (increasing yellow, poor feeding, lethargy, pale stools, dark urine). In HK, provide stool colour card at discharge.

Never Stop Breastfeeding for Breast Milk Jaundice

Breast milk jaundice is benign, and mother should be advised to continue breastfeeding based on other beneficial effects of breastmilk [3][6]. The bilirubin will gradually decline over 3–12 weeks. Temporary interruption of breastfeeding for diagnostic purposes (to see if TSB drops) is rarely needed and generally discouraged because it undermines breastfeeding establishment.

3B. Phototherapy — The Primary Treatment

Phototherapy ("photo" = light, "therapy" = treatment) is the mainstay of treatment for unconjugated neonatal hyperbilirubinaemia. It is by far the most commonly used intervention.

Phototherapy works by three photochemical reactions that convert unconjugated bilirubin (lipophilic, neurotoxic) into water-soluble photoisomers that can be excreted without hepatic conjugation:

  1. Structural isomerisation (photo-oxidation): Bilirubin → lumirubin (most important pathway). Lumirubin is water-soluble → excreted rapidly in bile and urine without requiring conjugation. This is the dominant clearance pathway.
  2. Configurational (geometric) isomerisation: Native bilirubin (4Z,15Z) → photobilirubin (4Z,15E or 4E,15Z). These isomers are more polar → excreted in bile. Reversible — can revert to native form.
  3. Photo-oxidation: Small contribution — bilirubin broken down into colourless, water-soluble fragments.

Why does the light need to be blue-green (wavelength 460–490 nm)? Because this is the absorption spectrum of bilirubin — light at this wavelength is maximally absorbed by bilirubin molecules in the skin and subcutaneous tissue, driving the photochemical conversion.

TypeDescriptionIndication
Conventional (standard) phototherapySingle overhead light source (fluorescent, LED, or fibreoptic)TSB at or above phototherapy threshold for age
Intensive phototherapyMultiple light sources (overhead + underneath fibreoptic blanket) → maximises irradiance and body surface area exposedTSB rapidly rising, approaching exchange transfusion threshold, or in high-risk zone
AspectDetail
PositionBaby undressed (maximise skin exposure) with only a nappy. Eye shields (opaque) to protect retinae from phototoxicity
DistanceLight source as close to baby as possible (for conventional units, typically 30–50 cm; LED can be closer) — irradiance is inversely proportional to distance
FeedingContinue breastfeeding. Remove baby from phototherapy for feeds (intermittent phototherapy is acceptable for feeding)
MonitoringTSB every 4–6 hours initially under phototherapy to assess response. Once falling, can space to every 12–24 hours.
HydrationPhototherapy increases insensible water loss (evaporation from exposed skin) → may need to increase fluid intake by ~10–20%. Monitor urine output and weight.
When to stopWhen TSB falls to a level at least 35–50 µmol/L (2–3 mg/dL) below the phototherapy threshold for that age. Check rebound TSB 12–24 hours after stopping — especially important in haemolytic disease where rebound can occur.

The AAP 2022 revised clinical practice guideline (replacing the 2004 guideline) recommends phototherapy based on:

  • TSB level plotted against postnatal age in hours on an age-specific nomogram
  • Gestational age (lower thresholds for lower GA)
  • Neurotoxicity risk factors — which lower the phototherapy threshold by approximately one risk category:
    • GA 35–37+6 weeks (late preterm)
    • Albumin < 3.0 g/dL
    • Isoimmune haemolytic disease (positive DAT)
    • G6PD deficiency
    • Sepsis
    • Clinical instability in the previous 24 hours
    • Significant lethargy
GAApproximate Phototherapy Threshold at 48hAt 72h
≥ 38 weeks, no risk factors~15 mg/dL (257 µmol/L)~18 mg/dL (308 µmol/L)
≥ 38 weeks, with risk factors~13 mg/dL (222 µmol/L)~15 mg/dL (257 µmol/L)
35–37+6 weeks, no risk factors~13 mg/dL (222 µmol/L)~15 mg/dL (257 µmol/L)
35–37+6 weeks, with risk factors~11 mg/dL (188 µmol/L)~13 mg/dL (222 µmol/L)

(These are approximate guides — always use the published nomogram charts in clinical practice)

SituationReasoning
Conjugated hyperbilirubinaemiaPhototherapy is ineffective (conjugated bilirubin is already water-soluble — it does not need photoisomerisation). Worse, phototherapy can cause "bronze baby syndrome" — deposition of photodegradation products of conjugated bilirubin in skin → bronze-grey discolouration. Harmless but alarming and cosmetically distressing.
Congenital erythropoietic porphyria (CEP) or other porphyriasPhototherapy can trigger severe phototoxic blistering skin reactions

High Yield — Phototherapy is for UNCONJUGATED Hyperbilirubinaemia Only

Phototherapy does NOT work for conjugated hyperbilirubinaemia — conjugated bilirubin is already water-soluble so photo-isomerisation is irrelevant. Using phototherapy on a baby with conjugated jaundice can cause bronze baby syndrome and delays the workup for the real underlying cause (e.g., biliary atresia). Always fractionate bilirubin before starting phototherapy.

Side EffectMechanism
Insensible water loss / dehydrationIncreased evaporation from exposed skin under radiant heat
Temperature instabilityExposed baby loses heat; some units radiate warmth
Loose green stoolsPhotoisomers excreted in bile → osmotic diarrhoea
Skin rash (erythema)Photosensitivity
Bronze baby syndromeOnly with conjugated hyperbilirubinaemia (see above)
Retinal damage (if eyes unshielded)UV/blue light phototoxicity → hence mandatory eye shields
Interference with parent-infant bondingBaby under lights, eyes covered → parents feel separated; encourage kangaroo care during breaks

AspectDetail
IndicationIsoimmune haemolytic disease (positive DAT due to ABO or Rh incompatibility) where TSB is rising despite intensive phototherapy and approaching the exchange transfusion threshold [7][15]
MechanismIVIG blocks Fc receptors on reticuloendothelial system macrophages (in spleen and liver) → reduces antibody-mediated destruction of antibody-coated neonatal RBCs → slows haemolysis → ↓ bilirubin production
Dose0.5–1 g/kg IV over 2 hours. Can be repeated once in 12 hours if needed.
GoalReduce the need for exchange transfusion
Side effectsRare: allergic reactions, fluid overload, necrotising enterocolitis (NEC) risk in preterm (some concern from observational data)

3D. Exchange Transfusion — The Rescue Treatment

Exchange transfusion is the definitive emergency treatment for severe unconjugated hyperbilirubinaemia when phototherapy and IVIG fail, or when bilirubin levels are dangerously high and/or there are signs of acute bilirubin encephalopathy (ABE) [3][7][15].

A double-volume exchange transfusion (≈ 160–170 mL/kg for a term neonate, since blood volume ≈ 80–85 mL/kg) removes approximately:

  • ~85% of circulating antibody-coated RBCs (in immune haemolysis)
  • ~50% of intravascular bilirubin (bilirubin re-equilibrates from extravascular compartment afterwards)
  • Circulating maternal antibodies

Fresh donor blood (cross-matched against mother's serum, usually group O Rh-negative or compatible) replaces the removed blood.

IndicationDetail
TSB at or above the exchange transfusion threshold on the AAP 2022 nomogramThresholds are approximately 3–5 mg/dL above the phototherapy threshold and vary by GA and risk factors
TSB not responding to intensive phototherapy (continues rising rapidly)Rate of rise > 8.5 µmol/L/h (0.5 mg/dL/h) despite intensive phototherapy
Signs of acute bilirubin encephalopathy (ABE)Hypertonia, arching (opisthotonos/retrocollis), high-pitched cry, seizures — proceed immediately regardless of TSB level
Severe anaemia with cardiac compromise (haemolytic disease)Hydrops fetalis, severe Rh disease
Postnatal AgeNo Risk FactorsWith Risk Factors
24 hours~19 mg/dL (325 µmol/L)~17 mg/dL (291 µmol/L)
48 hours~22 mg/dL (376 µmol/L)~19 mg/dL (325 µmol/L)
72 hours~24 mg/dL (410 µmol/L)~21 mg/dL (359 µmol/L)

(Lower thresholds for preterm infants — consult local nomograms)

Key teaching point: Aim to intervene before TSB reaches the risky level ( < 340 µmol/L / < 20 mg/dL in term) with a lower threshold in preterm infants [3].

  • Performed in NICU with continuous cardiorespiratory monitoring
  • Access: umbilical venous catheter (UVC) — tip positioned in IVC/right atrium
  • Aliquots of 5–20 mL are withdrawn and replaced alternately with fresh donor blood
  • Duration: ~1–2 hours
  • Blood: Usually group O Rh-negative, irradiated, CMV-negative, fresh ( < 7 days old)

Why Irradiated Blood for Exchange Transfusion?

Exchange transfusion involves introducing a large volume of donor blood into an immunologically immature neonate. Non-irradiated blood contains viable donor lymphocytes that can engraft in the neonate's bone marrow → transfusion-associated graft-versus-host disease (TA-GVHD), which is almost universally fatal. Irradiation (25 Gy) destroys donor lymphocytes while preserving RBC function [22].

ComplicationMechanism
Electrolyte disturbances (hypocalcaemia, hyperkalaemia, hypomagnesaemia)Citrate anticoagulant in donor blood chelates calcium; stored blood leaks potassium
Cardiac arrhythmia / arrestFrom electrolyte shifts (especially hypocalcaemia → ↓ ionised Ca²⁺ → QT prolongation)
Thrombocytopenia / coagulopathyDilution of platelets and clotting factors
Infection / sepsisInvasive procedure; contamination risk
Air embolismVia UVC
NECGut ischaemia from haemodynamic shifts
HypothermiaLarge volume of cold blood infused
Rebound hyperbilirubinaemiaBilirubin re-equilibrates from tissues after exchange → always continue phototherapy post-exchange and monitor TSB Q4–6h
Mortality~0.3–0.5% in modern NICUs — hence exchange transfusion is reserved for when benefits clearly outweigh risks

AgentMechanismUse in Neonatal Jaundice
PhenobarbitoneInduces hepatic UGT1A1 (UDPGT) → ↑ conjugation; also ↑ ligandin → ↑ hepatic bilirubin uptake; ↑ bile flowNot routinely used for treatment of NNJ (too slow onset — takes 3–5 days). Main role is pre-treatment before EHIDA scan to differentiate biliary atresia from neonatal hepatitis [14]. Historical use in Crigler-Najjar type II (responsive).
Tin-mesoporphyrin (Stannsoporfin)Competitive inhibitor of haem oxygenase → ↓ bilirubin production at sourceInvestigational — FDA approved in some contexts. Not yet widely used in routine clinical practice. Potential to reduce need for phototherapy.
Albumin infusion↑ Bilirubin-binding capacity in blood → ↓ free bilirubin → ↓ neurotoxicity riskSometimes given before exchange transfusion (1 g/kg) in hypoalbuminaemic neonates to "mop up" free bilirubin. Not a standalone treatment.
Clofibrate↑ Conjugation (induces UGT)Used in some centres as adjunct to phototherapy; not standard of care

CauseSpecific Treatment
ABO / Rh incompatibilityPhototherapy ± IVIG ± exchange transfusion as above
G6PD deficiencyAvoid oxidant triggers (mothballs, fava beans, sulfonamides, certain TCMs); supportive (transfusion if severe anaemia); folic acid supplementation [22b]
Infection / sepsis / UTIAppropriate antimicrobials (e.g., ampicillin + gentamicin for empirical neonatal sepsis; targeted therapy after culture results)
HypothyroidismLevothyroxine replacement — early treatment preserves brain development
Crigler-Najjar type ILong-term phototherapy (10–12h/day), liver transplantation (definitive cure)
Crigler-Najjar type IIPhenobarbitone (responsive — ↑ residual UGT activity)
Hereditary spherocytosisFolic acid; transfusion if severe; splenectomy deferred until > 6 years [14b]
PolycythaemiaPartial exchange transfusion with normal saline (to reduce Hct) if symptomatic
Breastfeeding jaundiceImprove feeding technique and frequency; lactation support; supplement if severe dehydration

4. Management of Conjugated Hyperbilirubinaemia (Neonatal Cholestasis)

This is an entirely different management pathway. Phototherapy and exchange transfusion have NO role here — conjugated bilirubin is already water-soluble and does not cause kernicterus. The focus is on:

  1. Identify and treat the underlying cause
  2. Nutritional support (universal for all cholestatic infants)
  3. Medical therapy where applicable
  4. Surgical intervention for obstructive causes
  5. Liver transplantation as definitive treatment when needed

ComponentRationaleDetails
MCT-based formulaIn cholestasis, bile salt secretion into gut is ↓ → impaired emulsification and absorption of long-chain triglycerides (LCTs). Medium-chain triglycerides (MCTs) are absorbed directly into portal circulation without requiring bile salts for micelle formation.Pregestimil, Pepti-Junior, or similar MCT-enriched formula
Fat-soluble vitamin supplementation (A, D, E, K)↓ Bile salts → ↓ fat absorption → ↓ absorption of fat-soluble vitamins → deficiency statesVitamin K (1 mg IM or IV — prevents coagulopathy/bleeding); Vitamin D (oral cholecalciferol — prevents rickets); Vitamin A (oral); Vitamin E (oral α-tocopherol — prevents neuromuscular dysfunction). Monitor serum vitamin levels routinely [3][15][23]
Caloric supplementationCholestatic infants have high metabolic demands and poor absorptionAim for 120–150% of normal caloric requirement for age
ProteinAdequate protein for growthStandard protein intake unless hepatic encephalopathy (extremely rare in neonates — do not restrict protein unless absolutely necessary)

Ursodeoxycholic Acid — Indication and Contraindication

Ursodeoxycholic acid (UDCA) is commonly used for intrahepatic cholestasis (e.g., Alagille syndrome, PFIC, neonatal hepatitis). It works by displacing toxic hydrophobic bile acids from the bile acid pool, promoting choleresis (bile flow), and has cytoprotective effects on hepatocytes. Dose: 10–20 mg/kg/day divided BD–TDS.

However, UDCA is contraindicated in extrahepatic biliary obstruction (e.g., biliary atresia before Kasai) — because stimulating bile flow against a complete obstruction worsens hepatocyte damage [15]. After a successful Kasai procedure with restored bile flow, UDCA is then started as part of post-operative medical therapy [23].

4B. Management of Biliary Atresia — The Surgical Priority

Biliary atresia is the most important surgical cause of neonatal cholestasis and the most common indication for paediatric liver transplantation [3][9].

AspectDetail
PrincipleA Roux-en-Y loop of jejunum is anastomosed to the cut surface of the porta hepatis (where the obliterated ducts are transected) → bile drains from microscopic patent ductules at the liver surface directly into the jejunal conduit → bypasses the fibrotic extrahepatic ducts [3][10]
TimingIdeally before 60 days of life [10][23]. 60% achieve bile drainage (clear jaundice) if done before 12 weeks [3]; success rate drops significantly after 12 weeks. If diagnosed later than 6 weeks, some centres abandon Kasai and proceed directly to liver transplant listing [23].
Post-operative medical therapyUrsodeoxycholic acid (now safe — bile flow has been restored); Prophylactic antibiotics (e.g., co-trimoxazole or ciprofloxacin) to prevent ascending cholangitis via the jejunal conduit (which lacks a sphincter of Oddi); continued nutritional support and fat-soluble vitamins [10][23]
Outcomes70–80% early biliary drainage rate; 70–80% 5-year native liver survival (but the majority still develop progressive cirrhosis and portal hypertension) [10]. ~50% will eventually require liver transplantation.
Pre-operative preparationCorrect coagulopathy (vitamin K, FFP if needed); nutritional optimisation [10]
AspectDetail
IndicationFailed Kasai procedure (persistent jaundice post-Kasai); progressive liver failure; growth retardation / failure to thrive despite nutritional support; recurrent cholangitis; portal hypertension with complications (variceal bleeding, intractable ascites) [3][23]
TypesWhole liver (from deceased donor), split-liver (one donor organ shared between a child and an adult), living-donor (left lateral segment from a parent — preferred in HK due to organ scarcity)
Outcome~90% 5–10 year survival — comparable to transplantation for non-BA indications [3]
Post-transplantLifelong immunosuppression (tacrolimus-based regimen in most paediatric centres); monitoring for rejection, infection, PTLD (post-transplant lymphoproliferative disorder), renal toxicity

CauseTreatment
Choledochal cystComplete surgical excision of the cyst + cholecystectomy + Roux-en-Y hepaticojejunostomy [10][23]. Do NOT simply drain — risk of cholangiocarcinoma with residual cyst lining.
Neonatal hepatitis (idiopathic)Supportive: nutritional support, fat-soluble vitamins. Most self-limiting. Monitor for progression.
GalactosaemiaImmediate dietary elimination of galactose (stop all lactose-containing feeds → switch to soy-based formula) [23]. Delays worsen liver and brain damage.
Tyrosinaemia type 1Nitisinone (NTBC) — inhibits 4-hydroxyphenylpyruvate dioxygenase → prevents accumulation of toxic fumarylacetoacetate + dietary restriction of tyrosine and phenylalanine → liver transplant if refractory
α₁-antitrypsin deficiencyNo specific enzyme replacement for liver disease. Supportive. Liver transplant for decompensated cirrhosis.
PNACReduce IV lipid dose; advance enteral feeds as tolerated; consider fish-oil based lipid emulsion (SMOFlipid/Omegaven) which is less hepatotoxic than soybean-based emulsions [15]
Alagille syndromeUDCA for cholestasis; nutritional support; partial external biliary diversion (PEBD) for intractable pruritus; liver transplant if decompensated
PFIC types 1–3UDCA; biliary diversion surgery (PEBD or ileal exclusion); BSEP stabiliser (investigational for type 2); liver transplant
Bile acid synthesis defectsOral cholic acid — replaces missing primary bile acids, suppresses production of toxic intermediates
GALD (neonatal haemochromatosis)Exchange transfusion + high-dose IVIG (removes circulating maternal alloantibodies + blocks complement-mediated hepatocyte injury); liver transplant if acute liver failure

LevelTreatmentIndication
Level 0Optimise feeding + monitoringTSB below phototherapy threshold, baby well
Level 1Phototherapy (conventional)TSB at or above phototherapy threshold
Level 2Intensive phototherapy (multiple light sources)TSB rising rapidly, approaching exchange threshold, or not responding to conventional phototherapy
Level 3IVIG (if isoimmune haemolysis) + intensive phototherapyTSB rising despite intensive phototherapy in immune haemolytic disease
Level 4Exchange transfusionTSB at or above exchange threshold, or signs of ABE, or failure of all above

GroupFollow-Up Plan
Uncomplicated physiological jaundiceTcB/TSB check 24–48h post-discharge if discharged early ( < 72h of age); community midwife/nurse assessment; stool colour card education
Post-phototherapyRebound TSB 12–24h after stopping phototherapy (especially if haemolytic cause); clinic review in 1–2 weeks
Post-exchange transfusionClose NICU follow-up; developmental surveillance (risk of hearing loss even if kernicterus averted); audiology referral
Biliary atresia (post-Kasai)Lifelong follow-up — serial LFT, growth monitoring, liver USS, endoscopy for varices if portal hypertension develops; pre-transplant workup if failing
G6PD deficiencyParental education on avoidance of oxidant triggers (mothballs, fava beans, sulphonamides, aspirin in high doses, certain TCMs); carry G6PD alert card; genetic counselling (X-linked)
Congenital hypothyroidismLevothyroxine with regular TFT monitoring; developmental assessment

High Yield Summary — Management of Neonatal Jaundice

  1. Unconjugated NNJ: Optimise feeding → Phototherapy (blue-green light, 460–490 nm, converts UCB to lumirubin) → IVIG (for isoimmune haemolysis) → Exchange transfusion (double-volume, last resort).
  2. Phototherapy thresholds are based on age-in-hours, gestational age, and neurotoxicity risk factors (AAP 2022 nomogram).
  3. Phototherapy is contraindicated in conjugated hyperbilirubinaemia — causes bronze baby syndrome and delays real diagnosis.
  4. Exchange transfusion removes ~85% of antibody-coated RBCs and ~50% of intravascular bilirubin. Use irradiated, CMV-negative, fresh blood. Complications: electrolyte shifts (hypocalcaemia!), infection, NEC, mortality ~0.3–0.5%.
  5. Conjugated NNJ: NO phototherapy. Nutritional support (MCT formula + fat-soluble vitamins A, D, E, K) for ALL. UDCA for intrahepatic cholestasis (contraindicated in extrahepatic obstruction until bile flow restored).
  6. Biliary atresia: Kasai portoenterostomy ideally before 60 days → post-op UDCA + prophylactic antibiotics → liver transplant if Kasai fails. BA is the most common indication for paediatric LT.
  7. Galactosaemia: Immediate dietary galactose elimination (soy formula).
  8. G6PD deficiency: Avoidance of triggers + supportive treatment.
  9. Always treat the underlying cause alongside managing the bilirubin level.
  10. Family-centred care: Explain treatment, educate on stool colour card, support breastfeeding, genetic counselling where appropriate.

Active Recall — Management of Neonatal Jaundice

References

[3] Senior notes: Adrian Lui Pediatrics Notes.pdf (pp. 46–49, 264) [6] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p. 668) [7] Unconjugated hyperbilirubinemia in newborns ≥35 weeks of gestation: Etiology and pathogenesis - UpToDate.pdf (p. 1) [9] Lecture slides: GC 146. A jaundiced child.pdf (pp. 35, 48) [10] Senior notes: Maksim Surgery Notes.pdf (pp. 121, 333) [14] Senior notes: Ryan Ho Diagnostic Radiology.pdf (pp. 64, 82) [14b] Senior notes: Ryan Ho Haemtology.pdf (p. 39) [15] Paediatrics in Review - Jaundice - Newborn to Age 2 Months.pdf (pp. 9–10) [22] Senior notes: Block A - Fever after a blood transfusion: transfusion and related problems.pdf (p. 22) [22b] Senior notes: Block A - Family history of anaemia: inherited causes of anaemia; haemolytic anaemia; aplastic anaemia.pdf (p. 21) [23] Senior notes: Maksim Paediatric Notes.pdf (pp. 85–86)

Complications of Neonatal Jaundice

The complications of neonatal jaundice fall into two broad categories: those arising from unconjugated hyperbilirubinaemia (bilirubin neurotoxicity) and those arising from conjugated hyperbilirubinaemia / neonatal cholestasis (progressive hepatobiliary damage and its sequelae). There are also complications of the treatments themselves. We will cover each systematically.


1. Complications of Unconjugated Hyperbilirubinaemia

The central feared complication is bilirubin-induced neurological dysfunction (BIND). To understand it, you need to understand the concept of "free" (unbound) bilirubin.

Why does unconjugated bilirubin damage the brain, but conjugated bilirubin does not?

  • Unconjugated bilirubin (UCB) is lipophilic (fat-soluble). It normally circulates tightly bound to albumin, which is too large to cross the blood-brain barrier (BBB). As long as UCB remains albumin-bound, it cannot enter the brain.
  • When the albumin-binding capacity is overwhelmed — either because the UCB level is extremely high, or because albumin is low, or because competing substances displace UCB from albumin — free (unbound) UCB enters the circulation.
  • Free UCB, being lipophilic, readily crosses the BBB. It is directly toxic to neurons via:
    • Mitochondrial toxicity (uncouples oxidative phosphorylation → energy failure)
    • Excitotoxicity (↑ glutamate release)
    • Oxidative stress (generates reactive oxygen species)
    • Apoptosis of neurons
  • The brain regions with the highest metabolic rate and the least myelination are most vulnerable: basal ganglia (globus pallidus, subthalamic nucleus), brainstem auditory nuclei (cochlear nuclei, inferior colliculus), hippocampus, and oculomotor nuclei.
  • Conjugated bilirubin, by contrast, is hydrophilic (water-soluble). It does not cross the BBB and therefore does NOT cause kernicterus — instead, elevated conjugated bilirubin reflects underlying hepatobiliary disease [3][4].

Severe neonatal hyperbilirubinemia is defined as TSB > 428 µmol/L (25 mg/dL) — this level carries a significantly ↑ risk of BIND [4].

ABE is the acute clinical manifestation of bilirubin neurotoxicity. It is potentially reversible if recognised and treated urgently (with exchange transfusion) [3][4].

Clinical features progress through three phases:

PhaseTimingFeaturesPathophysiology
EarlyFirst 1–2 daysLethargy, hypotonia, poor feeding, poor suckInitial neuronal depression from bilirubin mitochondrial toxicity
IntermediateNext 1–2 daysIrritability, high-pitched cry, hypertonia (alternating with hypotonia)Progressive neuronal injury, especially basal ganglia irritability
AdvancedBeyondOpisthotonos (severely arched back), retrocollis (arched neck), fever, apnoea, seizures → may progress to coma and deathSevere, widespread neuronal necrosis; brainstem compromise

High Yield — ABE Warning Signs

The earliest signs of ABE are often subtle and non-specific — lethargy, poor feeding, hypotonia. These overlap with many other neonatal conditions (sepsis, metabolic disease). A high index of suspicion is required in any jaundiced neonate. If a jaundiced baby becomes "too sleepy" or "not feeding well" — check the TSB urgently.

The word "kernicterus" literally means "kern" (nucleus, German) + "icterus" (jaundice) — referring to the yellow staining of the basal ganglia and brainstem nuclei seen at autopsy.

Kernicterus is the chronic, irreversible form of BIND. If ABE is not treated in time, permanent neurological damage ensues [3][4].

The classic kernicterus tetrad:

FeatureBrain Region AffectedExplanation
Dystonic / choreoathetoid cerebral palsyGlobus pallidus, subthalamic nucleus (basal ganglia)Bilirubin selectively destroys the extrapyramidal motor system → involuntary writhing movements (athetosis), abnormal posturing (dystonia). NOT spastic CP — this is specifically extrapyramidal.
Sensorineural hearing loss (SNHL)Cochlear nuclei, inferior colliculus (brainstem auditory pathway)Auditory nuclei in the brainstem are highly vulnerable to bilirubin toxicity. SNHL can range from mild (auditory neuropathy spectrum disorder) to profound deafness. May occur even without other features of kernicterus — this is why all jaundiced neonates at risk should have auditory brainstem response (ABR) testing.
Upward gaze palsyVertical gaze centres in the midbrain (rostral interstitial nucleus of MLF)Bilirubin damages the midbrain nuclei controlling vertical eye movements → eyes are "sunset" (unable to look upward)
Dental enamel dysplasia / greenish-brown teeth discolourationDeveloping enamel-forming cells (ameloblasts)Bilirubin is deposited in developing dental structures during amelogenesis

Additional features may include: intellectual disability (variable severity, may be mild or severe), seizure disorder, and general developmental delay [3][4].

Key exam point: Kernicterus causes extrapyramidal (dystonic/choreoathetoid) cerebral palsy, NOT pyramidal (spastic) CP. This is because bilirubin targets the basal ganglia, not the corticospinal tracts.

Risk FactorMechanism
PrematurityImmature BBB (more permeable), lower albumin levels, lower albumin-binding affinity, developing brain is more susceptible
Hypoalbuminaemia↓ Binding capacity → ↑ free UCB at any given TSB level
AcidosisH⁺ ions compete for bilirubin-binding sites on albumin → ↓ binding affinity → ↑ free UCB
Sepsis / infectionOpens BBB; causes acidosis and hypoalbuminaemia; ↑ bilirubin production from haemolysis
Drugs displacing bilirubin from albuminCeftriaxone, sulfonamides, ibuprofen — compete for the same binding site on albumin → ↑ free UCB
Haemolytic diseaseRapid ↑ in UCB can overwhelm binding capacity; also produces free fatty acids that displace bilirubin
Asphyxia / hypoxiaDisrupts BBB integrity; causes acidosis
Hypothermia↓ Albumin binding affinity
HypoglycaemiaImpairs neuronal energy reserves → neurons more susceptible to bilirubin toxicity

Even when kernicterus is prevented, there is emerging evidence that moderate-to-severe neonatal hyperbilirubinaemia may be associated with subtle neurodevelopmental effects including:

  • Auditory processing difficulties (auditory neuropathy spectrum disorder — ANSD)
  • Mild cognitive deficits
  • Behavioural problems

This is why all neonates with significant jaundice (especially those requiring phototherapy or exchange transfusion) should be referred for audiology follow-up (ABR testing) and developmental surveillance [7].


2. Complications of Conjugated Hyperbilirubinaemia / Neonatal Cholestasis

Conjugated bilirubin itself is NOT directly neurotoxic. However, the diseases that cause conjugated hyperbilirubinaemia lead to a cascade of serious complications related to cholestasis and progressive liver disease [3][9][10][23].

Why does cholestasis cause fat-soluble vitamin deficiency?

  • Bile salts are required for emulsification and absorption of dietary fats in the small intestine.
  • In cholestasis, bile salt secretion into the gut is reduced → fat malabsorption → fat-soluble vitamins (A, D, E, K) are not absorbed.
  • This leads to specific deficiency syndromes:
VitaminDeficiency ManifestationMechanismClinical Relevance in Neonates
Vitamin KCoagulopathy / bleeding (haemorrhagic disease of the newborn, easy bruising, GI bleeding, intracranial haemorrhage)↓ Vitamin K → ↓ carboxylation of factors II, VII, IX, X → ↑ PT/INROften the presenting feature; can be life-threatening. Prolonged PT/INR in a cholestatic neonate should be treated with parenteral (IM or IV) vitamin K — oral vitamin K is ineffective in cholestasis due to malabsorption.
Vitamin DRickets, osteopenia↓ Vitamin D → ↓ calcium absorption → ↓ bone mineralisationMay present with pathological fractures, widened wrists/ankles, frontal bossing if chronic
Vitamin EHaemolytic anaemia, neuromuscular dysfunction (peripheral neuropathy, cerebellar ataxia, retinopathy)Vitamin E is an antioxidant protecting cell membranes; deficiency → oxidative damage to RBCs and neuronsOften subclinical initially; neuromuscular complications develop over months–years if untreated
Vitamin ANight blindness, xerophthalmia, keratomalacia↓ Vitamin A → ↓ rhodopsin in retinal rods; ↓ epithelial integrityRarely clinically apparent in neonates (detected by monitoring serum vitamin A levels)

  • Fat malabsorption → caloric deficit (fat is the most calorie-dense macronutrient)
  • Steatorrhoea — fatty, foul-smelling, bulky stools
  • ↓ Absorption of essential fatty acids (linoleic, linolenic acid) → can impair brain development
  • Chronic liver disease itself increases metabolic demand
  • Result: poor weight gain, failure to thrive, growth retardation — a common indication for liver transplantation [3]

  • In biliary atresia, even after a successful Kasai procedure, the intrahepatic disease typically continues to progress → progressive fibrosis → biliary cirrhosis [3][10].
  • Majority of biliary atresia patients still develop cirrhosis and portal hypertension even with initial bile clearance after Kasai [10].
  • Death < 2 years if biliary atresia is untreated [3].

As cirrhosis develops, portal pressure rises (resistance to portal blood flow through the fibrotic liver). This leads to:

ComplicationMechanismClinical Features
Splenomegaly and hypersplenismPortal hypertension → congestion of spleen → splenic enlargement → sequestration of blood cellsPalpable spleen; thrombocytopenia, leucopenia, anaemia
Oesophageal and gastric varicesPortal blood diverts through collateral veins (including submucosal oesophageal veins) → dilated, fragile varicesRisk of variceal haemorrhage — haematemesis, melaena; can be life-threatening
AscitesPortal hypertension + hypoalbuminaemia (↓ hepatic synthetic function) → ↑ hydrostatic pressure + ↓ oncotic pressure → transudation of fluid into peritoneal cavityAbdominal distension, fluid thrill, shifting dullness
Hepatopulmonary syndromeIntrapulmonary vascular dilatation → V/Q mismatchDyspnoea, cyanosis, clubbing (rare in neonates; more common in older children with chronic liver disease)

After Kasai portoenterostomy, the Roux-en-Y jejunal conduit lacks a sphincter of Oddi → intestinal bacteria can ascend into the biliary system → recurrent ascending cholangitis [10][23].

  • Presents with: fever, worsening jaundice, pale stools, acholic urine
  • Can accelerate liver damage and cirrhosis
  • Managed with IV antibiotics (e.g., ampicillin + gentamicin ± metronidazole) and prophylactic oral antibiotics (e.g., co-trimoxazole) are given long-term post-Kasai to reduce episodes [10]

  • Chronic cholestasis and cirrhosis from any cause carry an increased risk of HCC, though this is more relevant in older children/adolescents with long-standing liver disease.

  • Choledochal cysts carry a ~2% risk of cholangiocarcinoma [3][23]. This is why complete excision (not just drainage) is mandatory.

3. Complications of Treatment

ComplicationMechanism
Insensible water loss / dehydration↑ Evaporation from exposed skin under radiant heat
Temperature instabilityNaked baby under lights → heat gain or loss depending on environment
Loose green stools ("phototherapy diarrhoea")Photoisomers excreted in bile → osmotic effect in gut
Erythematous skin rashPhotosensitivity reaction
Bronze baby syndromeOnly occurs with conjugated hyperbilirubinaemia — photodegradation products of conjugated bilirubin deposit in skin → grey-bronze discolouration. Cosmetically alarming but not harmful. Clears after phototherapy is stopped.
Retinal damageUV/blue light phototoxicity → mandatory eye shields during phototherapy
Disruption of parent-infant bondingBaby under lights with eyes covered → parents may feel distanced; encourage skin-to-skin during feed breaks
Separation from mother → breastfeeding disruptionMay undermine breastfeeding establishment if not proactively supported

Bronze Baby Syndrome — A Complication of Incorrect Indication

Bronze baby syndrome occurs when phototherapy is used on a baby with conjugated (not unconjugated) hyperbilirubinaemia. This is why bilirubin must ALWAYS be fractionated before starting phototherapy. The bronze discolouration is benign, but the real danger is that using phototherapy on a cholestatic baby delays the crucial workup for biliary atresia or other surgical causes.

ComplicationMechanismPrevention/Management
HypocalcaemiaCitrate anticoagulant in stored donor blood chelates ionised calcium → ↓ iCa²⁺ → QT prolongation → risk of arrhythmia/cardiac arrestMonitor iCa²⁺; give slow IV calcium gluconate 10% (0.5–1 mL/kg) after every 100 mL of blood exchanged
HyperkalaemiaStored blood leaks potassium from RBCs over timeUse fresh blood ( < 7 days old); monitor K⁺
Thrombocytopenia / coagulopathyDilution of platelets and clotting factors during exchangeCheck post-exchange CBC and coagulation; transfuse platelets/FFP if needed
Infection / sepsisInvasive procedure (UVC); donor blood contaminationStrict asepsis; prophylactic antibiotics at some centres
Air embolismVia umbilical venous catheterCareful technique; Luer-lock connections
NEC (necrotising enterocolitis)Gut ischaemia from haemodynamic shifts during exchange; especially in preterm infantsWithhold feeds during and briefly after exchange
Rebound hyperbilirubinaemiaBilirubin re-equilibrates from extravascular compartment into blood after exchangeContinue phototherapy post-exchange; monitor TSB Q4–6h
HypothermiaLarge volume of cold blood infusedUse blood warmer
Graft-versus-host disease (TA-GVHD)Viable donor lymphocytes engraft in immunologically immature neonate → attack host tissuesUse irradiated blood products
MortalityAll of the above~0.3–0.5% in modern NICUs

ComplicationDetail
Allergic / anaphylactoid reactionRare; present with rash, hypotension
Fluid overloadLarge-volume protein infusion in a small neonate
Possible NEC associationSome observational data suggest ↑ NEC risk in preterm infants receiving IVIG; not definitively established
Interference with live vaccinesIVIG contains passive antibodies that may interfere with MMR/varicella vaccine efficacy for several months

Underlying CauseLong-Term Complications
G6PD deficiencyRecurrent haemolytic crises with future oxidant exposures (infections, drugs, foods); chronic haemolysis → pigmented gallstones; aplastic crises (parvovirus B19)
Hereditary spherocytosisChronic haemolytic anaemia; pigmented gallstones (50% of adults) [14]; aplastic crises; post-splenectomy overwhelming sepsis (OPSI)
Rh haemolytic diseaseLate anaemia (persistent maternal anti-D destroying neonatal RBCs for weeks after birth → may need "top-up" transfusions); iron overload if multiple transfusions
Congenital hypothyroidism (if missed)Cretinism: mental retardation, puffy face, deafness, mutism, protuberant abdomen, umbilical hernia; short stature and growth retardation in older children [8]
GalactosaemiaCataracts (2 weeks), liver failure, E. coli sepsis, renal tubular acidosis, intellectual disability, ovarian failure in females — even with treatment, some cognitive effects may persist [23]
Biliary atresia (post-Kasai)Recurrent cholangitis, progressive cirrhosis, portal hypertension, growth failure, need for liver transplantation [3][10][23]
Choledochal cystCholangitis, ~2% risk of cholangiocarcinoma [3][23]
α₁-antitrypsin deficiencyProgressive cirrhosis in childhood; emphysema in adulthood (panacinar, lower lobes); HCC
Alagille syndromeChronic cholestasis with severe pruritus; cardiac disease (peripheral pulmonary stenosis — often the cause of mortality); renal tubular disorder; growth failure [3]
PFICProgressive cirrhosis requiring liver transplant; severe pruritus; hearing loss (PFIC1) [3]

All neonates who have experienced significant hyperbilirubinaemia (particularly those who required phototherapy, exchange transfusion, or had evidence of haemolytic disease) should have:

Follow-UpRationale
Auditory brainstem response (ABR) testingSNHL is one of the earliest and sometimes ONLY manifestation of subclinical bilirubin neurotoxicity. Newborn hearing screening by otoacoustic emissions (OAE) alone may miss auditory neuropathy spectrum disorder (ANSD) — ABR is more sensitive.
Developmental surveillanceMonitor gross/fine motor milestones, language, cognition at standard intervals (6 weeks, 6 months, 12 months, 18 months, 2–3 years). Early intervention if concerns.
Growth monitoringEspecially important in cholestatic infants — plot weight, length, head circumference on age-appropriate growth charts.
Ophthalmology reviewIf galactosaemia (cataracts) or kernicterus (upward gaze palsy) suspected

High Yield Summary — Complications of Neonatal Jaundice

  1. BIND is the feared complication of unconjugated hyperbilirubinaemia — free UCB crosses the BBB and is toxic to basal ganglia, brainstem auditory nuclei, and midbrain.
  2. ABE (acute bilirubin encephalopathy) is the acute, potentially reversible phase: lethargy → hypertonia → opisthotonos → seizures → death.
  3. Kernicterus is the chronic, irreversible phase: dystonic/choreoathetoid CP, SNHL, upward gaze palsy, dental dysplasia, intellectual disability.
  4. Kernicterus causes extrapyramidal (NOT spastic) CP — because it targets the basal ganglia.
  5. Conjugated bilirubin does NOT cause kernicterus — but signals serious hepatobiliary disease leading to fat-soluble vitamin deficiency (K → coagulopathy, D → rickets, E → haemolytic anaemia/neuropathy, A → night blindness), growth failure, progressive cirrhosis, portal hypertension, and need for liver transplantation.
  6. Biliary atresia → progressive cirrhosis even post-Kasai; recurrent cholangitis; most common indication for paediatric liver transplant.
  7. Choledochal cyst → cholangitis + ~2% cholangiocarcinoma risk.
  8. Treatment complications: phototherapy → dehydration, bronze baby syndrome (if conjugated); exchange transfusion → hypocalcaemia (most dangerous — QT prolongation), hyperkalaemia, thrombocytopenia, NEC, TA-GVHD (prevented by irradiated blood), mortality ~0.3–0.5%.
  9. All at-risk neonates need ABR testing (hearing), developmental surveillance, and growth monitoring.

Active Recall — Complications of Neonatal Jaundice

References

[3] Senior notes: Adrian Lui Pediatrics Notes.pdf (pp. 46–49, 264–265) [4] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (pp. 308, 313) [7] Unconjugated hyperbilirubinemia in newborns ≥35 weeks of gestation: Etiology and pathogenesis - UpToDate.pdf (p. 1) [8] Senior notes: Block A - I am losing weight and sweating all the time: causes of severe weight loss; thyrotoxicosis; hypothyroidism.pdf (p. 41) [9] Lecture slides: GC 146. A jaundiced child.pdf (pp. 2, 35, 48) [10] Senior notes: Maksim Surgery Notes.pdf (pp. 331, 333) [14] Senior notes: Ryan Ho Haemtology.pdf (p. 26) [15] Paediatrics in Review - Jaundice - Newborn to Age 2 Months.pdf (pp. 1, 7) [23] Senior notes: Maksim Paediatric Notes.pdf (pp. 85–86)

High Yield Summary

  1. Neonatal jaundice is the most common clinical condition in neonates — > 50% term, > 80% preterm, higher in Asians.
  2. Physiological jaundice is due to ↑ bilirubin production (high Hct, short RBC lifespan), ↓ conjugation (immature UDPGT), and ↑ enterohepatic circulation (sterile gut, low feeding volumes). It appears after 24h, peaks Day 3–5, and resolves by 2 weeks.
  3. Jaundice < 24 hours = ALWAYS pathological → think haemolysis (ABO, Rh, G6PD).
  4. G6PD deficiency is the most important enzymopathy in Hong Kong Chinese males (~4–6%) — screened at birth.
  5. Prolonged jaundice ( > 2 weeks term / > 3 weeks preterm) → MUST fractionate bilirubin (split conjugated vs unconjugated).
  6. Conjugated hyperbilirubinaemia is NEVER physiological → urgent investigation to exclude biliary atresia (surgical emergency — Kasai before 60 days ideal).
  7. Biliary atresia is the most common indication for paediatric liver transplant. Clues: persistent acholic stools, dark urine, hepatomegaly.
  8. BIND / Kernicterus is caused by unconjugated bilirubin crossing the BBB → damages basal ganglia → acute: opisthotonos, seizures; chronic: dystonic CP, SNHL, upward gaze palsy.
  9. Ceftriaxone is avoided in jaundiced/hypoalbuminaemic neonates (displaces bilirubin from albumin).
  10. Stool colour card is used in Hong Kong to screen for biliary atresia at the 1-month check.

High Yield Summary — Differential Diagnosis of Neonatal Jaundice

  1. First step: fractionate bilirubin → unconjugated vs conjugated. This dictates the entire differential.
  2. Second step: timing → early ( < 24h), normal (24h–2w), or prolonged ( > 2w term / > 3w preterm).
  3. Jaundice < 24 hours = haemolysis until proven otherwise (ABO > Rh > G6PD > membrane defects > congenital infection).
  4. Physiological jaundice is a diagnosis of EXCLUSION — must rule out pathological causes first.
  5. Breastfeeding jaundice ≠ breast milk jaundice: the former = inadequate intake (baby losing weight); the latter = breast milk substances inhibiting conjugation (baby thriving).
  6. Prolonged conjugated jaundice → MUST exclude biliary atresia — it is surgically treatable but time-critical (Kasai before 60 days). Acholic stools are the key clue.
  7. Biliary atresia vs neonatal hepatitis: persistent acholic stools + very high GGT + contracted GB on USG + no intestinal excretion on EHIDA → biliary atresia. Confirmed by operative cholangiogram (gold standard).
  8. HK-specific: G6PD screening at birth (cord blood), congenital hypothyroidism screening (cord TSH), stool colour card at 1-month check for biliary atresia, citrin deficiency is relatively common in Chinese.
  9. Conjugated bilirubin does NOT cause kernicterus — but signals serious hepatobiliary disease.
  10. UTI is an easily missed cause of neonatal jaundice — always check urine in any unexplained jaundice.

High Yield Summary — Diagnostic Approach to Neonatal Jaundice

  1. Step 1 — Screen: TcB (non-invasive) → if elevated, confirm with serum TSB → plot on Bhutani nomogram.
  2. Step 2 — Fractionate: Always determine conjugated vs unconjugated bilirubin. This is THE branch point.
  3. Step 3 — Unconjugated pathway: CBC, PBS, reticulocyte count, blood group + Coombs test, G6PD assay, LDH. Looking for haemolysis.
  4. Step 4 — Conjugated pathway (cholestasis): Full LFT (especially GGT), coagulation profile, albumin, glucose, USG abdomen, urine culture, TORCH screen, metabolic screen. Looking for biliary atresia, neonatal hepatitis, IEM.
  5. Step 5 — Biliary atresia workup: Fasting USG (contracted GB, triangular cord sign) → EHIDA scan (no intestinal excretion after phenobarbitone pre-treatment) → liver biopsy (bile duct proliferation, portal fibrosis) → operative cholangiogram (gold standard).
  6. Step 6 — Prolonged jaundice ( > 2 weeks term / > 3 weeks preterm): MUST fractionate bilirubin. If unconjugated → check TFT, urine culture, feeding adequacy. If conjugated → cholestasis pathway (as above).
  7. Physiological jaundice = diagnosis of exclusion. Unconjugated only, normal enzymes, no haemolysis, well baby, resolves by 2 weeks.
  8. Conjugated hyperbilirubinaemia is NEVER physiological → always warrants urgent investigation.
  9. In HK: cord blood G6PD screen (males), cord TSH screen, stool colour card at 1 month.

High Yield Summary — Management of Neonatal Jaundice

  1. Unconjugated NNJ: Optimise feeding → Phototherapy (blue-green light, 460–490 nm, converts UCB to lumirubin) → IVIG (for isoimmune haemolysis) → Exchange transfusion (double-volume, last resort).
  2. Phototherapy thresholds are based on age-in-hours, gestational age, and neurotoxicity risk factors (AAP 2022 nomogram).
  3. Phototherapy is contraindicated in conjugated hyperbilirubinaemia — causes bronze baby syndrome and delays real diagnosis.
  4. Exchange transfusion removes ~85% of antibody-coated RBCs and ~50% of intravascular bilirubin. Use irradiated, CMV-negative, fresh blood. Complications: electrolyte shifts (hypocalcaemia!), infection, NEC, mortality ~0.3–0.5%.
  5. Conjugated NNJ: NO phototherapy. Nutritional support (MCT formula + fat-soluble vitamins A, D, E, K) for ALL. UDCA for intrahepatic cholestasis (contraindicated in extrahepatic obstruction until bile flow restored).
  6. Biliary atresia: Kasai portoenterostomy ideally before 60 days → post-op UDCA + prophylactic antibiotics → liver transplant if Kasai fails. BA is the most common indication for paediatric LT.
  7. Galactosaemia: Immediate dietary galactose elimination (soy formula).
  8. G6PD deficiency: Avoidance of triggers + supportive treatment.
  9. Always treat the underlying cause alongside managing the bilirubin level.
  10. Family-centred care: Explain treatment, educate on stool colour card, support breastfeeding, genetic counselling where appropriate.

High Yield Summary — Complications of Neonatal Jaundice

  1. BIND is the feared complication of unconjugated hyperbilirubinaemia — free UCB crosses the BBB and is toxic to basal ganglia, brainstem auditory nuclei, and midbrain.
  2. ABE (acute bilirubin encephalopathy) is the acute, potentially reversible phase: lethargy → hypertonia → opisthotonos → seizures → death.
  3. Kernicterus is the chronic, irreversible phase: dystonic/choreoathetoid CP, SNHL, upward gaze palsy, dental dysplasia, intellectual disability.
  4. Kernicterus causes extrapyramidal (NOT spastic) CP — because it targets the basal ganglia.
  5. Conjugated bilirubin does NOT cause kernicterus — but signals serious hepatobiliary disease leading to fat-soluble vitamin deficiency (K → coagulopathy, D → rickets, E → haemolytic anaemia/neuropathy, A → night blindness), growth failure, progressive cirrhosis, portal hypertension, and need for liver transplantation.
  6. Biliary atresia → progressive cirrhosis even post-Kasai; recurrent cholangitis; most common indication for paediatric liver transplant.
  7. Choledochal cyst → cholangitis + ~2% cholangiocarcinoma risk.
  8. Treatment complications: phototherapy → dehydration, bronze baby syndrome (if conjugated); exchange transfusion → hypocalcaemia (most dangerous — QT prolongation), hyperkalaemia, thrombocytopenia, NEC, TA-GVHD (prevented by irradiated blood), mortality ~0.3–0.5%.
  9. All at-risk neonates need ABR testing (hearing), developmental surveillance, and growth monitoring.

On this page

No Headings